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Summary 
Main project: Inhibition of transcription during in vitro maturation of bovine 
oocytes 
 
The release of a mature oocyte from the ovary is a prerequisite for successful 
reproduction. In the bovine, oocytes are arrested in prophase I prior to ovulation. Completion 
of oocyte meiosis and the first embryonic cleavages are under the control of maternal gene 
products. Maternal transcripts and proteins are accumulated and stored during oogenesis and 
gradually depleted until the embryonic genome activation  
To assess the impact of transcription inhibition during maturation on the protein 
composition of the oocytes, a holistic proteomic analysis of GV oocytes and MII oocytes 
matured with or without the presence of actinomycin D (ActD) was performed. Using a 
label-free LC-MS/MS-based approach, substantial quantitative proteomic changes were 
identified between mature and immature oocytes, as well as due to inhibition of transcription. 
Bioinformatic analysis of this set of proteins was carried out using DAVID gene ontology 
(GO) and gene set enrichment analysis (GSEA) to gain insight into the related biological 
processes and molecular functions. Among the enriched gene sets in MII control compared 
to GV are GO terms related to cell cycle and RNA processing, reflecting the progression of 
meiosis and the importance of protein synthesis during maturation.  
Proteins increased or decreased after maturation irrespective of ActD-treatment were 
determined and related biological processes independent of de novo transcription were 
identified. Beside cell cycle-related proteins, proteins that increase despite the absence of 
transcription were found to be involved in the organization of cellular components, which is 
crucial for cytoplasmic maturation. On the contrary, de novo transcription-dependent 
proteins were associated with cell-cell adhesion and translation. As the high degree of 
protein synthesis has been shown to be related with good developmental competence, this 
indicates the disturbed maturation in the presence of ActD. Thus, the study provides new 
insights into the protein profiles before and after maturation and indicates that de novo 
transcription is absolutely essential for successful maturation 
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Side projects: Bovine reproductive fluids in high-yielding dairy cows 
 
Concomitant with intensive selection for increased milk yield, reproductive 
performance of dairy cows has declined in recent decades, in part due to an unfavorable 
genetic relationship between these traits. The causes of this decline in reproductive success 
are multi-factorial with higher milk yield being shown to have an inverse relationship with 
the pregnancy rates observed in dairy cows. Early embryonic loss is a major cause of this 
reduced pregnancy rate. Successful fertilization, implantation and establishment of 
pregnancy is dependent on good quality embryos, an appropriate oviductal and endometrial 
environment, and the successful interaction between the embryo and the endometrium. 
Within the FECUND project, two animal models have been created to study the effect of 
two conditions with adverse impact on the reproductive performance, a different genetic 
merit for fertility, i.e. cows with distinct reproductive traits and a different metabolic status 
of the animal (post-partum metabolic stress) on reproductive tissues and fluids.  
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Side project A: Proteomic analysis of uterine luminal fluid in pregnant cows  
 
To study the effect of genetic merit for fertility on the proteome of the uterine luminal 
fluid (ULF), Holstein heifers with low (LFH) and high fertility (HFH) index and heifers from 
the Montbéliarde breed (MBD), known to have good reproductive performance, were 
investigated. To focus on the maternal effect, heifers from all three groups were 
synchronized and received on Day 7 high-quality embryos from superovulated and 
artificially inseminated MBD donors. ULF from Day 19 pregnant heifers was analyzed in a 
holistic proteomic approach using nano-LC-MS/MS analysis combined with a label-free 
quantification approach. In total, 1,737 proteins were identified, of which 597 were found to 
differ significantly in abundance between the three groups. The majority of proteome 
differences in ULF samples was found comparing the HFH and MBD groups to the LFH 
group, showing that the genetic predisposition for fertility is prevalent regarding the ULF 
protein composition. Evaluation of this dataset using bioinformatic tools comprising DAVID 
gene ontology and gene set enrichment analysis revealed that higher abundant proteins in 
the LFH group are assigned to several metabolic processes as well as the immune response. 
Our study unveiled that the genetic merit for fertility leads to substantial quantitative 
differences at the level of proteins in uterine fluid of pregnant animals, thus altering the 
microenvironment for the early conceptus. 
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Side project B: Proteomic analysis of bovine oviduct fluid 
 
The oviduct plays a crucial role in fertilization and early embryo development 
providing the microenvironment for oocyte, spermatozoa, and early embryo. Analyzing two 
animal models, this study aimed to investigate the impact of genetic predisposition for 
fertility as well as of metabolic stress on the protein composition of oviduct fluid (OF). The 
metabolic model comprised maiden Holstein heifers (MH) and postpartum lactating (Lact) 
and non-lactating (Dry) cows, while the genetic model consisted of heifers from the 
Montbéliarde (MBD) breed and Holstein heifers with low (LFH) and high (HFH) fertility 
index. Holistic proteomic analysis of OF from all groups using nano-LC-MS/MS analysis 
and label-free quantification led to the identification of 1637 proteins, amongst which 128 
showed abundance alterations in the pairwise comparisons within both models. Most 
differentially abundant proteins were revealed between LFH and MBD (52) in the genetic 
model and between Lact and MH (19) in the metabolic model, demonstrating a substantial 
effect of genetic predisposition for fertility as well as of metabolic stress on the OF proteome. 
Functional classification of affected proteins revealed actin binding, translation and immune 
system processes as prominent GO clusters. Notably, actin-related protein 2/3 complex 
subunit 1B (ARPC1B) and the three immune system-related proteins SERPIND1, IGK 
protein and alpha-1-acid glycoprotein (AGP) were affected in both models, suggesting that 
abundance changes of immune-related proteins in OF play an important role for early 
embryonic loss. 
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1 Introduction 
1.1 Early mammalian development 
One of the major drawbacks for reproductive success in mammals are disturbances in 
ovulation, fertilization and early embryonic development. At prenatal age, oocytes begin to 
develop in the ovaries until maturation is arrested at the late fetal stage and resumption of 
oocyte meiosis is only resumed after the first menstrual or estrus cycle, regarding humans 
and primates or non-primate mammals, respectively. In monovulatory species – like bovine 
and human - this resumption of maturation is caused in response to the gonadotropin 
luteinizing hormone (LH) and leads to release of the mature metaphase II (MII) oocyte  into 
the infundibulum of the oviduct, which connects the ovary and the uterus. In humans, 
ovulation is induced at approximately Day 14 of the menstrual cycle, while in cattle, estrus 
is referred to as Day 0 and marks the receptiveness of the female. Contemporaneously with 
LH, follicle-stimulating hormone (FSH) levels reach their peak and exhibit a synergistic 
action (1). Elevated estrogen levels result in the hypothalamic secretion of gonadotropin-
releasing hormone from the pituitary gland, subsequently triggering FSH and LH release. In 
humans, the ensuing luteal phase is characterized by progesterone secretions of the corpus 
luteum (CL), which stimulates endometrial growth in preparation of the implantation of an 
embryo.  
 
Figure 1: Development of the oocyte/embryo to the blastocyst stage. The trigger by the 
preovulatory LH surge induces meiotic resumption of the arrested germinal vesicle (GV) oocyte and 
maturation to the metaphase II (MII) stage. After ovulation, fertilization then leads to extrusion of the 
second polar body, followed by the first mitotic cell divisions – of which only selected stages are 
shown - until the blastocyst stage.  
 
After ovulation and the concomitant release of the oocyte into the oviduct, the oocyte 
is ready for fertilization, the trigger for meiotic resumption leading to the extrusion of the 
second polar body. After entrance of a spermatozoon, the membranes of the female and male 
pro-nuclei dissolve and combination of the chromosomes leads to the formation of a single 
diploid nucleus. The so-called zygote remains in the oviduct, where the first mitotic cell 
divisions take place. In the following period, the early bovine embryo stays in the oviduct 
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until it reaches the uterus at around Day 4 to 5 post-fertilization in cows. Embryonic 
cleavages and compaction of the embryo results in the formation of the morula together with 
the first lineage decision, which marks the loss of pluripotency. At around Day 7 in cattle 
and Day 5 to 6 in humans, the embryo reaches the blastocyst stage, which consists of the 
inner cell mass – the future embryo or fetus, which stems from the compacted inner 
blastomeres – and the trophectoderm, which will later give rise to the placenta (2, 3). The 
early embryonic development from the GV oocyte to the blastocyst stage is schematically 
illustrated in Figure 1. After hatching from its outer shell, the zona pellucida (ZP), the 
conceptus elongates and is implanted into the uterus at approximately Day 9 post fertilization 
in humans and around Day 19 in cattle (4, 5), establishing the contact between the conceptus 
and the endometrium, which nourishes the conceptus in the subsequent developmental 
stages. 
 
1.1.1 Oocyte maturation 
As described in the preceding section, oocytes have to undergo maturation prior to 
fertilization. Successful oocyte maturation is a prerequisite for fertilization and subsequent 
embryonic development. During fetal life, the mammalian oocyte initiates meiosis and, until 
ovulation or atresia of the oocyte, it is arrested at the germinal vesicle (GV) stage, which is 
the diplotene stage of prophase I. Acquisition of the competence for resumption of meiosis 
takes place during the oocytes’ growth phase (6), which is completed at a follicle diameter 
size of approximately 3 mm in cattle (7). Meiotic arrest is maintained by high cAMP levels 
in the oocyte, suppressing the activity of the maturation promoting factor (MPF) through 
stimulation of cAMP-dependent protein kinase A (PKA). In vivo, meiotic resumption is 
triggered by the pre-ovulatory gonadotropin surge that leads to decreasing cGMP levels in 
the follicle and oocyte, which results in an up-regulation of the activity of phosphodiesterase 
and finally causes a drop in intraoocyte cAMP levels (8-10). Resumption of meiosis then 
leads to germinal vesicle breakdown (GVBD), chromosomal condensation, expansion of the 
surrounding cumulus and progression through metaphase I to anaphase and telophase, finally 
leading to extrusion of the first polar body and arrest at metaphase II (MII) until fertilization 
and extrusion of the second polar body (11), as depicted in Figure 2. In vitro, meiotic 
resumption can also be induced by removal of the oocyte from the follicle, which has an 
inhibitory effect on the oocyte (12). In addition to the above-described events that occur 
during nuclear maturation, cytoplasmic maturation takes place, which involves major 
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changes in the cytoplasm such as reorganization of organelles and storage of mRNAs, 
proteins and transcription factors (13-16). Cytoplasmic maturation is comprehensively 
reviewed by Ferreira et al. (15) and can be divided into the main phases organelle 
redistribution, dynamics of the cytoskeleton and molecular maturation. 
 
Figure 2: Oocyte maturation. During their development in the follicle of the fetal ovary, oocytes 
become arrested at prophase I, the GV stage. LH surge (in vivo) or mechanical release from the 
follicle (in vitro) results in GV breakdown (GVBD). When the oocyte reaches metaphase I, condensed 
chromosomes (purple) align at the metaphase plate of the spindle (green). After extrusion of one set 
of chromosomes in the first polar body, the mature oocyte is arrested at metaphase II (MII) until 
fertilization (adapted from Adhikari and Liu (17)). 
 
In vitro maturation (IVM) of mammalian oocytes is an important technique for embryo 
technology as it directly affects the efficiencies of in vitro embryo production (IVP). The 
IVM of bovine oocytes enables the generation of larger quantities of mature oocytes than 
the expensive in vivo alternative, which requires the hormonally induced superovulation of 
cows. Cumulus-oocyte-complexes (COCs) for IVM and subsequent embryo production can 
be aspirated from the follicles of ovaries, readily available from local abattoirs. However, it 
has to be considered that oocytes collected this way often are of heterogeneous quality, due 
to differences in stage of the estrus cycle or genetic differences of the donor animals, with 
impact on IVP rates. Maturation can be induced by several different protocols, yet, one of 
the most commonly applied approaches involves the supplementation of IVM media with 
estrus cow serum (ECS). Moreover, addition of the gonadotropins FSH and LH has been 
shown to improve cumulus cell (CC) expansion, fertilization rates and subsequent 
embryonic development (18-20) and is therefore a commonly applied strategy with or 
without the supplementation of growth factors, e.g. epidermal growth factor. 
The IVM efficacy of oocytes is influenced by many factors like oocyte quality prior to 
maturation or the medium composition during the maturation process. Regarding the 
efficacy of IVP, it has been reported that approximately 90% of immature oocytes undergo 
nuclear maturation, approximately 80% are fertilizable in vitro (in vitro fertilization, IVF) 
while less than half 50% reach the blastocyst stage in cattle (11). Although this suggests that 
the major drop in IVP efficiency is caused by problems during the in vitro culture, the oocyte 
quality seems to be the limiting factor (21). This is underlined by the fact that the blastocyst 
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rate of in vitro matured oocytes is at a low rate of about 35% irrespective of in vitro or in 
vivo embryo culture, but the blastocyst rate significantly increases for in vivo matured 
oocytes regardless of the following culture conditions (21-23). Therefore, understanding 
underlying molecular mechanisms related to impaired oocyte quality and insufficient 
maturation is of major importance for successful in vitro generation of embryos. 
 
1.1.2 Role of transcription during in vitro maturation 
Several studies have previously aimed to elucidate underlying mechanisms of oocyte 
maturation and post-fertilization development. During the oocyte growth phase in fetal life, 
maternal transcripts are accumulated in the oocyte, which are critical for the control of 
subsequent resumption of meiosis and the first embryonic cell divisions (24, 25). It has been 
shown that in bovine embryos the major embryonic genome activation (EGA), which implies 
the switch from maternal RNAs and proteins stored in the oocytes to transcripts generated 
in the embryo, takes place at the 8-cell stage (26, 27). It is therefore assumed that fully grown 
mammalian GV stage oocytes already possess most of the transcripts necessary and that 
stored mRNAs are gradually degraded or translated, regulating embryonic developmental 
processes (28).  
Yet, the role of transcription during maturation of the oocyte is not fully understood. 
Transcriptional activity has been shown to occur to some extent in GV stage oocytes (6, 29), 
but there are conflicting results about the transcriptional activity after resumption of meiosis. 
Studies of mouse and human immature and in vivo matured oocytes showed an up-regulation 
of some transcripts during maturation (30, 31), while on the other hand, the absence of over-
expressed transcripts has been reported in immature compared to in vitro matured bovine 
and murine oocytes (32, 33). In addition, another study of bovine GV stage and in vitro 
matured oocytes detected a massive reduction of the initial transcript stock, but also reported 
elevated levels of certain transcripts during IVM, leading to the assumption that transcription 
takes place to a certain degree. Radiolabeling experiments to determine the amount of 
transcriptional activity in GV and MII oocytes and the subsequent early cleavage stages 
showed that 35S-UTP incorporation remains high at the GV stage but decreases to 
background levels at the MII stage, followed by an increase at the 2-cell stage (34), which 
is in agreement with the decrease of maturation rates from 90 to 75% in oocytes matured in 
the presence of the transcription inhibitor Actinomycin D (ActD) (35). However, these 
results implicate only minor transcriptional activity during maturation, whose function and 
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importance for maturation remains partially unclear and leaves space for further 
investigations. 
 
1.1.3 The bovine as model system 
Due to easier animal housing, most basic reproductive research has been conducted in 
mice. Yet, there are major differences in oocyte and early embryonic development between 
humans and mice (36). Regarding bovine and human, the cow is a relevant animal model for 
studies of reproductive biology, as it better reflects the human system. In contrast to e.g. 
mice and pigs, humans and cows are both single ovulating species. Moreover, they both have 
significantly longer estrus and menstrual cycles compared to mice, and oocyte biology and 
many aspects of follicular dynamics and oocyte size show a much higher degree of similarity 
between the bovine and the human system as compared to mice (37).  
Thus, the results of studies of murine oocytes and embryonic development can only be 
partially transferred to the human system. Therefore, the analysis of bovine oocyte 
maturation is not solely interesting for understanding and improving bovine reproductive 
processes and IVM, but may to a certain extent also increase the knowledge of these 
processes in humans and human IVF techniques. 
 
1.2 Targeting in vitro maturation on a molecular level 
Due to the small amounts of sample material as compared to tissues or cell culture 
derived samples, the analysis of oocytes and early embryos at the transcriptome and 
proteome level is challenging and was limited in the past, as it requires highly sensitive 
procedures and instrumentation. Therefore, the technological advances in mass-
spectrometry and RNA sequencing now allow a more thorough study of oocyte maturation, 
fertilization and embryonic development and the underlying molecular mechanisms. Thus, 
the following section will elaborate the results of, on the one hand, transcriptomic studies 
and, on the other hand, proteomic analyses of oocytes and the subsequent stages. 
 
1.2.1 Transcriptomic studies 
Bovine oocytes before and after maturation and the early embryonic developmental 
stages have been subject to numerous transcriptomic analyses so far. Regarding specifically 
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GV and MII oocytes, e.g. Fair et al. (38) performed a global mRNA expression analysis and 
detected three times more down- than up-regulated transcripts after IVM and showed that 
the majority of the detected genes is associated with regulatory activities including the 
regulation of mitogen-activated protein kinase (MAPK) activity, translation initiation and 
transcription. In addition, comparing in vivo and in vitro matured oocytes, affected 
transcripts in IVM oocytes were found to be related to metabolism, cell organization, cell 
growth or maintenance (39).  
Several studies also targeted the effect of different developmental capacities on the 
oocyte transcriptome. Adona et al. (40) analyzed the impact of IVM on the transcript profile 
of oocytes and detected that the genes altered by IVM are mostly related to the regulation of 
oocyte metabolism. Moreover, in a transcriptomic study of bovine GV oocytes with different 
developmental competence, differentially expressed genes were shown to be involved in 
regulation of transcription, translation and RNA processing (41), which was also confirmed 
in a similar approach conducted by Biase et al. (42). 
Beside the transcriptomic analysis of immature and mature oocytes, the developmental 
stages up to the blastocyst stage have also been investigated on the level of the transcriptome. 
For example Vigneault et al. (43) identified genes associated with the EGA and showed that 
a high proportion of genes at the 8-cell stage was involved in gene transcription and RNA 
processing. Another study by Graf et al. (26) performed a RNA-Seq analysis of different 
developmental stages, detecting on the one hand relatively few differentially abundant 
transcripts between GV and MII oocytes, and, on the other hand, a remarkable increase in 
differentially abundant transcripts between 4-cell and 8-cell stages, which marks the onset 
of the EGA. 
 
1.2.2 Mass spectrometry-based proteomic studies 
Although transcriptomic-based strategies have frequently been employed in oocytes 
and embryos, this does not give clear evidence of the corresponding protein levels, as there 
is no strict correlation between gene and protein expression levels, particularly in oocytes 
(44, 45). A large proportion of stored maternal mRNAs present in the oocyte is not 
polyadenylated and can therefore not be translated (46). Moreover, many proteins require 
post-translational modifications, such as phosphorylation, glycosylation or acetylation, for 
full functionality and also protein processing through proteolysis is not accessible via 
genome or transcriptome approaches (47-49). Therefore, proteomic analyses are 
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indispensable for understanding of molecular processes, especially during oocyte 
maturation.  
For several years, two-dimensional gel electrophoresis (2D-PAGE) was the method of 
choice for proteomic experiments. However, the technical progress in both liquid 
chromatography and mass spectrometry systems enabled the more and more sensitive 
analysis of whole proteomes. Using a bottom-up proteomic approach with nano liquid 
chromatography – tandem mass spectrometry, referred to as nano LC-MS/MS, proteins are 
analyzed at the peptide level. Therefore, protein lysates are digested by a protease, typically 
trypsin, as trypsin cleaves peptide chains mainly at the carboxyl side of the amino acids 
lysine or arginine. The obtained peptides are then separated in the chromatography system 
and are subsequently ionized and analyzed by the tandem mass spectrometer, which captures 
the peptide ion and creates peptide fragments through collision with gas molecules, the so-
called collision-induced dissociation (CID) (50, 51). As the peptides are predominantly 
fragmented at the peptide bond, this leads to a predictable pattern of fragments, the mass to 
charge ratios of which are then determined by the instrument. For protein identification, the 
obtained MS/MS spectra are matched with theoretical MS/MS spectra from databases of the 
respective organism.  
In addition to the identification of proteins, there are several methods that enable a 
relative quantification by LC-MS/MS via labelling or through a label-free approach. 
Labelling is based on the introduction of chemical tags with stable isotopes either 
metabolically during cell culture (Stable isotope labelling by amino acids in cell culture, 
SILAC) (52), on the protein level (Isotope-coded affinity tag, ICAT) (53) or on the level of 
peptides, e.g. TMT (Tandem mass tag) and iTRAQ (Isobaric tags for relative and absolute 
quantitation) labelling (54, 55). The isotope-coded tags enable a simultaneous, multiplexed 
analysis of different samples for a more accurate quantification. On the other hand, label-
free methods are less costly and require less sample material due to fewer work steps. Label-
free methods are either based on the signal intensity of the precursor ion – the peptide ion –
(56) or use the number of MS/MS spectra obtained for each peptide, which is referred to as 
“spectral counting” (57). 
Proteomic approaches have been used in several studies of mammalian oocytes and 
embryos, such as mouse (58-64), human (65) and pig (45, 66, 67). In comparison to the 
mouse, there are relatively few proteomic studies of bovine oocytes and embryos. Using an 
iTRAQ-based approach, Deutsch et al. (68) analyzed the proteome of MII oocytes, zygotes, 
2-cell and 4-cell embryos and found a considerable number of proteins, which increased in 
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abundance over these stages and detected proteins involved in the p53 pathway, in lipid 
metabolism and in mitosis. Berendt et al. (69) performed a 2D-DIGE-based (Two-
dimensional difference gel electrophoresis) approach to analyze immature and in vitro 
matured bovine oocytes and detected changes in the levels of proteins related to cell cycle 
processes as well as redox enzymes. Another study, which aimed to analyze the interaction 
between oocyte and CCs at the GV stage showed that proteins with higher expression in CCs 
are functionally related to cell communication, generation of precursor metabolites and 
energy as well as transport (70). Of interest, Chen et al. (71) applied an iTRAQ-based 
approach to the analysis of in vitro matured buffalo oocytes and found 173 differentially 
expressed proteins between GV and competent MII oocytes, as well as 147 proteins between 
MII oocytes that were either classified as competent or incompetent. They detected a large 
number of proteins involved in mRNA processing and cell cycle, proteins related to the 
ubiquitin-proteasome proteolytic pathway and proteins associated with protein transport.  
 
1.2.3 The transcription inhibitor actinomycin D 
Actinomycin D (ActD) is an antibiotic and antineoplastic compound of the 
actinomycin family isolated from Streptomyces strains. ActD contains two cyclic 
pentapeptide lactones connected to aminophenoxazine (Figure 3).  
 
Figure 3: Chemical structure of the transcription inhibitor actinomycin D 
 
It is used in the treatment of Wilm’s tumor, a childhood cancer of the kidneys, and 
gestational choriocarcinoma (72-74). In addition to its clinical application, ActD is widely 
used in research as transcription inhibitor. The mechanism of action of ActD is mediated 
through binding DNA irreversibly by intercalation of the phenoxazone ring at pairs of 
guanine and cytosine, which leads to the inhibition of transcription via blockage of RNA 
polymerases (75, 76). In addition, the pentapeptides of the ActD structure have been 
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described to be located in the minor groove of the DNA (77, 78). ActD provides an useful 
experimental tool due to its ability to shut off transcription fast by affecting all three 
eukaryotic polymerases, while class one transcription has been shown to be most sensitive 
to ActD (79). In Xenopus laevis, inhibition of transcription with ActD blocked the release of 
the oocytes from the follicle but did not inhibit progesterone-induced oocyte maturation (80). 
In bovine oocytes, ActD treatment led to dose-dependent decrease of maturation, cell 
cleavage and Day 8 blastocyst rate, the latter being almost completely inhibited (35). 
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1.3 Aim of the thesis 
Oocyte maturation is an essential step required for reproductive success, as oocyte 
quality impacts the subsequent developmental stages. It has been commonly accepted that 
bovine oocyte maturation is under the control of maternal transcripts stored in the oocyte 
during growth phase. Yet, several studies conducted aimed to target the role of transcription 
during oocyte in vitro maturation (IVM) and results indicated that, to a certain degree, 
transcription takes place.  
The main focus of the present work is therefore to investigate the impact of 
transcription during IVM on the oocyte proteome. To achieve this, oocytes are matured in 
the presence of a transcription inhibitor and the protein composition of oocytes before and 
after maturation is analyzed in a holistic proteomic approach. Using label-free relative 
quantification, protein abundance alterations are detected between germinal vesicle (GV) 
and control and transcription-inhibited metaphase II (MII) oocytes. The central question is 
whether, and to which extent, the absence of transcription during maturation affects the 
oocyte proteome. To address this, first the quantitative proteome at the initial and final stage 
of non-inhibited oocyte IVM is assessed in-depth. Proteins involved in meiosis resumption 
until arrest at the MII stage are studied and related cellular processes are identified.  
Moreover, proteomic alterations during inhibited compared to changes during non-
inhibited maturation will provide additional knowledge about the effect of the absence of 
transcription during IVM. Single proteins dependent or independent of transcription are 
identified and functionally classified to determine underlying biological processes that do or 
do not require transcription. Thus, this work presents a comprehensive analysis of proteomic 
changes associated with in vitro maturation in bovine oocytes.  
. 
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2 Material and Methods 
2.1 Materials 
2.1.1 Chemicals and reagents 
 
Reagent Supplier 
Acetonitrile, LC-MS grade Merck Millipore (Darmstadt, Germany) 
Actinomycin D  Sigma-Aldrich (Steinheim, Germany) 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich (Steinheim, Germany) 
Dithiothreitol (DTT) Roth (Karlsruhe, Germany) 
Estrous cow serum (ECS) Moorversuchsgut der LMU (Oberschleißheim, 
Germany) 
Follicle-stimulating hormone (FSH) Sioux Biochemical, IA, USA 
Formic acid (FA) Sigma-Aldrich (Steinheim, Germany) 
Iodoacetamide (IAA) Sigma-Aldrich (Steinheim, Germany) 
Luteinizing hormone (LH) Sioux Biochemical, IA, USA 
Lysyl endopeptidase, MS grade Fujifilm Wako Chemicals (Richmond, USA) 
Polyvinylpyrrolidone (PVP) Sigma-Aldrich (Steinheim, Germany) 
Potassium chloride Roth (Karlsruhe, Germany) 
Potassium dihydrogenphosphate Roth (Karlsruhe, Germany) 
Sodium chloride Roth (Karlsruhe, Germany) 
Sodium hydrogen phosphate Roth (Karlsruhe, Germany) 
Tissue culturen medium 199 (TCM 199) Minitüb (Tiefenbach, Germany) 
Tris-(2-carboxyethyl)-phosphine (TCEP) Roth (Karlsruhe, Germany) 
Tris Roth (Karlsruhe, Germany) 
Trypsin, sequencing grade, modified Promega (Madison, WI, USA) 
Urea Roth (Karlsruhe, Germany) 
Water, LC-MS grade Merck Millipore (Darmstadt, Germany) 
Table 1: List of reagents and solvents 
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2.1.2 Technical equipment 
 
Device Manufacturer 
Cell culture equipment, Nunc Thermo Fisher Scientific, Waltham, USA 
Centrifuge 5427 R Eppendorf, Köln, Germany 
Electronic aspirator pump, 3014 Labotect, Göttingen, Germany 
Incubator CB 53 Binder, Tuttlingen, Germany 
Q Exactive HF-X mass spectrometer Thermo Fisher Scientific, Waltham, USA 
Separation column PepMap RSLC C18, 2 µm, 100 Å, 
75 µm x 50 cm 
Thermo Fisher Scientific, Waltham, USA 
Stereomicroscope Stemi SV6 Zeiss, Jena, Germany 
Thermomixer 5436  Eppendorf, Köln, Germany 
Transferpettor 5 µl Brand, Wertheim, Germany 
Trap column Acclaim PepMap RSLC 100, C18, 
3 µm, 100 Å, 75 µm x 2 cm 
Thermo Fisher Scientific, Waltham, USA 
UltiMate 3000 RSLC nano System Thermo Fisher Scientific, Waltham, USA 
Ultrasonicator Sonopuls UW3200 Bandelin, Berlin, Germany 
Vacuum concentrator Bachofer, Reutlingen, Germany 
Vortex Genie 2 Bachofer, Reutlingen, Germany 
Table 2: Instruments and material for cell culture and analytics 
 
2.1.3 Software 
 
Software name Supplier 
BioVenn Tim Hulsen, Computational Drug Discovery (CDD), 
Nijmegen, The Netherlands 
Cytoscape v3.3.0 The Cytoscape Consortium, San Diego, CA, USA 
Cytoscape plug-in ClueGO v2.2.0 The Cytoscape Consortium, San Diego, CA, USA 
Cytoscape plug-in CluePedia v1.2.0 The Cytoscape Consortium, San Diego, CA, USA 
DAVID v6.8 Laboratory of Human Retrovirology and 
Immunoinformatics, Frederick, USA 
GraphPad Prism 8 GraphPad Software, San Diego, CA, USA 
GSEA v2.0 Broad Institute, Massachusetts, USA 
MaxQuant v1.6.1.0 Max-Planck-Institute of Biochemistry, Martinsried, 
Germany 
Microsoft Office 2013 Microsoft, Redmont, WA, USA 
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Perseus v1.5.8.0 Max-Planck-Institute of Biochemistry, Martinsried, 
Germany 
REVIGO Rudjer Boskovic Institute, Zagreb, Croatia 
STRING v11.0 STRING Consortium, Zurich, Switzerland 
Table 3: Software and online tools used for data evaluation 
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2.2 Methods 
2.2.1 Generation of oocytes 
For collection of cumulus-oocyte complexes (COCs), post-mortem bovine ovaries 
were obtained from a local abattoir and transferred to the laboratory in phosphate-buffered 
saline (PBS; 1 mM KH2PO4, 2 mM KCl, 8 mM Na2HPO4, 0.9 mM CaCl2, 0.49 mM MgCl2, 
0.8% NaCl). Ovaries were washed several times in PBS to remove blood and cell debris. 
COCs were aspirated by puncture and suction from 3−8 mm follicles with an 18-gauge 
needle and a vacuum pressure of approximately 60 mm Hg. Oocytes with a complete 
cumulus oophorus were selected from follicle fluid sediments, and were randomly assigned 
to one of the three groups GV, MII control and MII AD oocytes.  
COCs of the GV group were mechanically denuded by vortexing for 4 min and washed 
three times in 1 mL PBS containing 1 mg/mL polyvinylpyrrolidone (PVP) to remove the 
CCs. Denuded GV oocytes were evaluated microscopically and morphologically intact 
oocytes were collected, frozen on dry ice after removal of PBS and stored at -80 °C.  
 
2.2.2 In vitro maturation  
COCs of the MII and MII AD groups were washed three times in maturation media 
consisting of tissue culture medium 199 (TCM 199) supplemented with 5% estrous cow 
serum (ECS), 0.025 IU/mL b-FSH, and 0.0125 IU/mL b-LH. The COCs were transferred to 
four-well plates in groups of 35 in 400 µl of maturation media per well. Transcription was 
inhibited by addition of 2 µg/ml actinomycin D in 5% DMSO to COCs of the MII AD group. 
For the control MII group, DMSO was added in a final concentration of 0.01% in the 
maturation media to have the same DMSO concentration in both groups. COCs were 
matured for 23 h at 39 °C in a humidified atmosphere with 5% v/v CO2 in air. 
 
2.2.3 Collection of oocytes 
After maturation, oocytes were evaluated microscopically and were manually denuded 
separately for each batch by vortexing for 4 min in 1 mL PBS containing 1 mg/mL PVP. 
Denuded mature oocytes were washed three times in PBS/1 mg/mL PVP. After removal of 
PBS, MII control and MII AD oocytes were separately frozen on dry ice and stored at −80 °C 
until analysis.   
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2.2.4 Protein lysis and tryptic digest 
Samples were lysed in denaturation buffer (8 M urea, 50 mM Tris-HCl, pH 8.0) and 
ultrasonicated twelve times for 10 s. Cysteine residues were reduced during 30 min of 
incubation in 4 mM dithiothreitol (DTT) /2 mM tris(2-carboxyethyl)phosphine (TCEP) at 
56 °C followed by alkylation in 8 mM iodoacetamide (IAA) for 30 min at room temperature 
in darkness. Excess IAA was quenched by addition of DTT to a final concentration of 
10 mM. For digestion, samples were first incubated with Lys-C with a protease:protein mass 
ratio of 1:100 for 4 h at 37 °C and were then diluted to < 1 M Urea, followed by addition of 
trypsin with a protease:protein mass ratio of 1:50. Incubation was performed overnight at 37 
°C, and the peptide solution was subsequently dried using a vacuum concentrator and stored 
at -80 °C.  
 
2.2.5 LC-MS/MS analysis 
Digested samples were re-dissolved in 0.1% formic acid (FA) and separated using an 
UltiMate 3000 RSLC nano system with a PepMap C18 column (500 mm x 75 µm, 2 µm) at 
a constant flow rate of 250 nL/min. Peptides were separated using linear gradients that 
consisted of a first ramp from 3 to 25%B (100% acetonitrile, 0.1% FA) within 160 min, 
followed by a ramp to 40% B within 10 min and a third ramp to 85% B in 5 min. The liquid 
chromatography was coupled online to a Q Exactive HF-X mass spectrometer via liquid 
junction. For data acquisition, collision induced dissociation (CID) spectra were acquired, 
and acquisition cycles consisted of one full MS scan at a resolution of 60,000 and a mass 
range of 350 to 1600 m/z followed by 15 data dependent MS/MS scans at a resolution of 
15,000.  
 
2.2.6 Data processing and statistical analysis 
Spectral data (Thermo RAW files) were processed using MaxQuant version 1.6.1.0 
and the implemented label-free quantification (LFQ) option (56, 81). For protein 
identification, MS/MS spectra were searched against the bovine Uniprot database (April 
2018) using the Andromeda search engine. The ‘match between runs’ option was enabled 
with a match time window of 0.7 min and an alignment time window of 20 min. Unique and 
razor peptides were used for protein quantification. Trypsin and Lys-C were chosen as 
enzymes with a maximum of two missed cleavages allowed. Carbamidomethylation was 
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selected as fixed modification, and oxidation (M) was used as variable modification. All 
other parameters were set according to MaxQuant default settings.  
Further data analysis was performed using Perseus version 1.5.8.0. Protein 
identifications were filtered for at least five valid values in at least one group and missing 
values were imputed from normal distribution. LFQ intensities of precursor ions were log2-
transformed and t-tests of pairwise comparisons between the three groups were carried out. 
Proteins were considered as significantly altered in abundance with a t-test q-value of less 
than 0.05 and a log2-fold change of > |0.6|. 
 
2.2.7 Bioinformatic analysis 
Venn diagrams were created using the web application BioVenn provided on 
http://www.cmbi.ru.nl/cdd/biovenn/ (82). Database for Annotation, Visualization and 
Integrated Discovery (DAVID) functional annotation clustering (https://david.ncifcrf.gov) 
was performed separately for significantly higher or lower abundant proteins in each of the 
three pairwise comparisons for the GO terms “biological process”, “molecular function” and 
“cellular component” using the integrated Bos taurus dataset as background (83-85). Gene 
clusters of related biological functions showing an enrichment score above 1.3 were 
considered as relevant.  
Gene set enrichment analysis (GSEA) was carried out using the software GSEA v2.2.2 
provided by the Broad Institute (http://software. broadinstitute.org/gsea) (86, 87). For each 
pairwise comparison, LFQ intensities for all proteins were loaded into the GSEA software 
and the following parameters were set: Number of permutations: 1000; Collapse dataset to 
gene symbols: false; Permutation type: gene set; Max size: exclude larger sets: 500; Min 
size: exclude smaller sets: 5. Among the databases provided by the Broad Institute, the 
following gene sets were chosen for analysis: c2.cp.kegg.v5.1.symbols.gmt [Curated]; 
c5.bp.v5.1.symbols.gmt [Gene ontology]; c5.mf.v5.1.symbols.gmt [Gene ontology]. All 
other parameters were set to GSEA default values. Gene sets with an FDR q-value of less 
than 0.05 were considered as significant. 
To cluster the significantly enriched gene sets obtained by the GSEA into 
superordinate terms, the enriched gene sets for each comparison were submitted to the online 
tool REVIGO (http://revigo.irb.hr/) (88). 
For proteins showing lower or higher abundance in both MII groups compared to the 
GV groups, functional annotation enrichment analysis was carried out using the online tool 
STRING (https://string-db.org/) (89). 
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Proteins showing significant abundance alterations between control MII oocytes and 
GV oocytes were subjected to Cytoscape (v3.3.0) and the ClueGO (v2.2.0) and CluePedia 
(v1.2.0) plug-ins to create functional network analysis (90-92). GO tree levels 3 to 8 were 
displayed with a minimum number of three genes per cluster. For statistics, two-sided 
hypergeometric test and “Bonferroni step-down” was applied to calculate enrichment for 
terms and groups according to the GO biological process. For GO term connectivity the κ-
score was set to 0.4. 
 
Results   24 
 
3 Results 
To study proteomic changes in bovine oocytes during in vitro maturation, nano-LC-
MS/MS-based analysis was carried out. Hereby the following three experimental groups 
were analyzed: immature GV oocytes, in vitro matured MII oocytes and MII oocytes treated 
with the transcription inhibitor actinomycin D during IVM. For a statistically powerful 
evaluation, eight biological replicates were analyzed per group. Given that a bovine oocyte 
contains around 90 ng of total protein, for each of the biological replicates 25 oocytes, which 
were matured separately and which were morphologically evaluated for the presence of a 
polar body, were pooled to obtain approximately 2.3 µg total protein for LC-MS/MS 
analysis. Thus, for the eight replicates of each experimental group (GV, MII, MII AD), 200 
oocytes were collected, i.e. 600 oocytes in total. The experimental strategy is graphically 
illustrated in Figure 4. 
 
Figure 4: Experimental design. After aspiration of the follicles, oocytes are either denuded and 
collected prior to maturation or are matured in vitro with or without the transcription inhibitor 
actinomycin D.  
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3.1  Protein identifications among the developmental stages 
Overall, 2018 proteins were identified in the oocytes across all three groups, including 
GV, MII and MII AD with 8 biological replicates per group. The Venn diagram in Figure 
5A illustrates the overlap of the proteins identified in each of the different groups. A total of 
1263 proteins was commonly identified in GV, MII and MII AD oocytes, corresponding to 
62.6% of all protein identifications. The vast majority of proteins identified in a single group 
was detected in MII AD, namely 276 proteins, equal to 13.7% of all proteins, followed by 
MII and GV with 145 and 115 proteins, respectively, equivalent to 7.2% and 5.7% of the 
total set of proteins. The full list of identified proteins with the corresponding LFQ intensities 
is provided in Supplementary table 1. 
 
3.2 Reproducibility of the biological replicates 
To assess the reproducibility of the oocyte treatment and collection as well as of the 
sample processing and the LC-MS/MS-based analysis, the protein IDs in the eight replicates 
of each groups and their overlap were examined. Figure 5B illustrates that the replicates of 
the GV group showed the highest degree of similarity of the three groups with 61.0% of the 
protein IDs shared between all eight replicates, while approx. 30% were commonly 
identified in two to seven replicates and 8.9% were detected solely in a single replicate, 
respectively. The comparison of protein identifications within individual replicates within 
each group reveals higher heterogeneity between the eight replicates of the MII and the 
ActD-treated MII group regarding identified proteins. In MII and MII AD, 56.4% and 
51.6%, respectively, were found in all eight replicates and 13.5% and 20.9% were identified 
only in a single biological replicate. However, the higher number of protein IDs in only one 
of the eight replicates correlates with the higher number of protein identifications, namely 
1671 in MII AD as opposed to 1536 in MII and 1556 in GV oocytes. Regarding LFQ values 
of the proteins used for relative quantification, a high degree of similarity was observed 
among the replicates of each group. For further analysis, only LFQ values of proteins 
detected in at least five of the eight replicates in at least one of the three groups were used 
for relative quantification. Unsupervised hierarchical clustering of the respective LFQ 
intensities revealed a perfect separation between GV, MII and AD-treated MII oocytes, as 
shown in Figure 6A, while GV and MII AD oocytes are more closely related and separated 
from the MII group, which indicates disturbed maturation in MII AD. The principal 
component analysis (PCA) (Figure 6B), also demonstrates a strict separation between the 
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groups. Moreover, the PCA hints at a slightly higher degree of heterogeneity in the GV 
group, when regarding component 1, while replicates of the MII group cluster very closely 
together.  
Figure 5: (A) Venn diagram of protein identifications of the three groups shows that 63% are shared 
between all groups. (B) Overlap of the protein IDs among the eight biological replicates within 
each group is highest in the GV group. 
 
 
Figure 6: Unsupervised hierarchical clustering (A) and principal component analysis (B) of 
LFQ values of the proteins quantified in GV, MII and MII AD oocytes show a clear discrimination of 
the three groups. 
 
3.3 Quantitative proteome alterations 
To detect quantitative proteome alterations, pairwise comparisons were carried out 
between the three groups based on the LFQ intensities. In the comparisons of MII to GV 
oocytes, 294 proteins were abundance-altered and 225 were differentially abundant in MII 
AD compared to GV. The vast majority of significantly abundance-altered proteins was 
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detected comparing AD-treated and control MII oocytes with 393 significantly abundance-
altered proteins, corresponding to approx. one fifth (19.5%) of all identified proteins. Among 
these, 186 were decreased in MII AD, while 207 proteins were found to be increased in MII 
AD.  
  
 
MII versus GV 
 
MII AD versus GV 
 
 
Protein name 
 
 
Gene name 
 
 
P-value 
 
log2-fold 
change 
 
 
P-value 
 
log2-fold 
change 
 
Wee1-like protein kinase 2 
 
WEE2 
 
6.6E-12 
 
5.2 
 
1.1E-11 
 
5.1 
 
Bifunctional 3'-
phosphoadenosine 5'-
phosphosulfate synthase 2 
 
PAPSS2 
 
1.2E-06 
 
3.9 
 
4.6E-02 
 
1.4 
 
Hemoglobin subunit alpha  
 
HBA 
 
2.6E-03 
 
3.5 
 
1.2E-04 
 
2.2 
 
Cyclin-dependent kinases 
regulatory subunit 1 
 
CKS1B 
 
1.6E-05 
 
3.0 
 
6.0E-02 
 
1.6 
 
Filamin-A 
 
FLNA 
 
4.0E-05 
 
2.9 
 
8.5E-03 
 
2.1 
 
Securin 
 
PTTG1 
 
4.8E-07 
 
2.8 
 
4.5E-07 
 
2.9 
 
Cyclin-dependent kinases 
regulatory subunit 2 
 
CKS2 
 
3.5E-04 
 
2.7 
 
1.2E-03 
 
2.6 
 
Uncharacterized protein  
 
LOC112444303
 
3.2E-07 
 
2.7 
 
4.7E-02 
 
0.7 
 
Serine/threonine-protein 
kinase VRK1 
 
VRK1 
 
1.8E-09 
 
2.4 
 
1.0E-03 
 
1.9 
 
Bis(5'-adenosyl)-
triphosphatase 
 
FHIT 
 
2.6E-10 
 
2.4 
 
8.5E-05 
 
0.9 
 
Uncharacterized protein  
 
F1MLM3 
 
5.2E-06 
 
2.0 
 
8.7E-04 
 
1.8 
 
Nucleophosmin 
 
NPM1 
 
3.7E-08 
 
1.9 
 
7.6E-07 
 
1.5 
 
Pleckstrin homology domain-
containing family G member 1 
 
PLEKHG1 
 
9.1E-06 
 
1.9 
 
2.4E-05 
 
1.8 
 
Activated RNA polymerase II 
transcriptional coactivator p15 
 
SUB1 
 
6.2E-05 
 
1.7 
 
1.7E-02 
 
0.9 
 
Integrin alpha-2 
 
ITGA2 
 
2.3E-04 
 
1.7 
 
2.0E-03 
 
1.2 
Table 4: Top 15 proteins with higher abundance in both MII control and MII AD compared to 
GV 
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The full lists of abundance-altered proteins are provided in the appendix in 
Supplementary tables 2 to 4. Regarding MII control, 159 proteins were increased after 
maturation and 135 were decreased, while in MII AD, 97 were higher abundant after IVM 
and 128 were found to be decreased. Of interest, 75 proteins were differentially abundant in 
both GV versus MII as well as in GV versus MII AD, of which 31 were commonly increased 
and 34 were commonly decreased after maturation, such as y-box-binding protein 2 (YBX2), 
wee1-like protein kinase (WEE2), transforming acidic coiled-coil-containing protein 3 
(TACC3), zygote arrest 1 (ZAR1), stathmin (STMN1), filamin-A (FLNA) and securin 
(PTTG1). Moreover, 10 proteins were affected in opposite ways in MII AD than in MII 
control, e.g. histone H2B (HIST1H2BI), or 60S ribosomal protein L22 (RPL22). Proteins 
with lower or higher abundance, respectively, in GV compared to MII and MII AD are listed 
in Supplementary tables 5 to 7. The Top 15 proteins with higher abundance in MII and MII 
AD compared to GV are presented in Table 4. 
 
The log2-fold changes and p-values of the proteins within each pairwise comparison 
are plotted in Figure 7. Proteins with a log2-fold change > │0.6│ and a t-test p-value < 0.05 
are marked and proteins of interest are highlighted. As shown, the protein WEE2, which is 
well described in the context of oocyte maturation and development, is the protein with the 
highest abundance alteration in both MII versus GV and MII AD versus GV with a 36- and 
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35-fold increase (log2-fold change of 5.2 and 5.1), respectively, after maturation. Regarding 
the comparison of both MII groups, vimentin (VIM) and pterin-4-alpha-carbinolamine 
dehydratase (PCBD1) were found to be among the proteins with the highest decrease in MII 
AD compared to control MII oocytes: VIM and PCBD1 were 20- and 19-fold higher 
abundant in the control group, while, on the other hand, gamma-interferon-inducible 
lysosomal thiol reductase (IFI30) and importin subunit alpha (KPNA2) were 6- and 5-times 
higher abundant in MII AD. 
 
3.4 Functional characterization of proteome alterations 
For functional characterization of the identified proteins, DAVID gene ontology 
analysis was carried using the GO terms “cellular component”, “biological process”, 
“molecular function” and the KEGG pathways for abundance-altered proteins of the 
respective pairwise comparisons, regarding up- and down-regulated proteins separately.  
Significantly (Enrichment score > 1.3) GO terms in GV compared to MII were 
“nucleotide-excision repair, DNA damage recognition”, “lysosome”, “nuclear membrane”, 
“carbohydrate metabolic process” and “ubiquitin mediated proteolysis”, while “RNA 
binding”, “cell-cell adhesion”, “translational initiation”, “carbon metabolism” and “innate 
immune response” were the top 5 enriched GO terms in MII compared to GV. Additionally, 
the ClueGO network shown in Figure 8 illustrates the processes to which the proteins that 
were significantly altered in the respective pairwise comparisons are related to. Proteins 
enriched in MII (blue nodes) were predominantly assigned to numerous nucleotide and 
nucleoside metabolic processes as well as mRNA-related processes. Moreover, a smaller 
cluster including meiosis I and oocyte maturation and development was found to be 
associated with the higher abundant proteins in mature oocytes. 
Comparing AD-treated MII oocytes to GV, only the GO terms “RNA binding” and 
“cell-cell adhesion” were enriched in GV. Proteins with higher abundance in MII AD were, 
among others, assigned to the following GO terms: “cell-cell adhesion”, “extracellular 
matrix organization”, “cell division” and “focal adhesion. The GO analysis of altered 
proteins in MII control compared to MII AD oocytes lead to the identification of 11 cluster 
enriched in MII, of which “RNA binding”, “nucleotide binding”, “cell-cell adhesion”, 
“mitochondrial inner membrane” and “carbon metabolism” were the five GO terms with the 
highest enrichment score. 
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Figure 8: ClueGO of significantly altered proteins in the comparison of GV and MII. Red nodes 
represent GO cluster that are enriched in the GV stage compared to the MII stage, while blue nodes 
correspond to cluster of proteins that are more abundant in the MII group. 
 
On the other hand, among the eight GO terms enriched in MII AD were “nucleotide 
excision repair, DNA damage recognition”, “ubiquitin-dependent protein catabolic process”, 
“translational initiation”, “cell-cell adhesion”, “lysosome” and “Golgi organization”. 
Supplementary tables 9 to 11 provide the full list of enriched GO terms for the respective 
pairwise comparisons together with the associated proteins. In addition, DAVID GO was 
performed for proteins with significantly higher levels in MII compared to GV, but which 
are not increased in MII AD over GV, resulting in eight enriched GO cluster. Among these, 
the cluster related to RNA binding showed the highest enrichment score, followed by “cell-
cell adhesion”, “spliceosomal complex” and “nucleosome”, which are listed in 
Supplementary table 12.  
For a comprehensive analysis of the dataset and validation of the results of the DAVID 
GO analysis, a gene set enrichment analysis (GSEA) was carried out for every pairwise 
comparison using the gene set databases KEGG pathway and the GO categories biological 
process and molecular function.  
Results   31 
 
 
 
Figure 9: Summary of the results of the GSEA. Enriched gene sets in MII (A) and MII AD (B) 
compared to GV and MII compared to MII AD (C) are clustered in superordinate GO terms using 
REVIGO. For each set, the number of proteins is depicted in brackets. Identical bar colors correspond 
to the same umbrella terms stated in the legend. 
 
 
Name 
 
GO ID 
 
size FDR q-value 
 
GO nucleic acid binding transcription factor activity GO:0003700 20 0.003 
 
GO meiotic cell cycle GO:0051321 16 0.009 
 
GO meiotic cell cycle process GO:1903046 15 0.009 
 
GO rRNA metabolic process GO:0016072 57 0.010 
 
GO ncRNA processing GO:0034470 62 0.011 
 
KEGG ribosome - 55 0.011 
 
GO nuclear chromatin GO:0000790 18 0.012 
 
GO poly a RNA binding GO:0008143 242 0.012 
 
GO ribosome biogenesis GO:0042254 65 0.012 
 
GO nuclear transcribed mRNA catabolic process nonsense 
mediated decay 
 
GO:0000184 
 
59 
 
0.012 
Table 5: Top 10 gene sets significantly enriched in MII compared to GV oocytes. 
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While the DAVID GO analysis shows enriched GO terms for the set of significantly 
abundance-altered proteins, the GSEA is based on the LFQ values of all identified proteins 
in the respective comparison and calculates enriched gene sets based on these intensities. 
Therefore, GSEA data are complementary to the DAVID analysis data. Gene sets were 
considered as significantly enriched with a false discovery rate (FDR) q-value of less than 
0.05. All significantly enriched gene sets are listed in Supplementary tables 13 to 15. In both 
comparisons of MII oocyte groups – MII control and AD-treated MII – to the GV stage, no 
gene set was significantly enriched in GV compared to the MII groups. However, several 
gene sets higher in MII and MII AD than in GV were identified. Among the 38 enriched sets 
in MII, the top five were “nucleic acid binding transcription factor activity”, “meiotic cell 
cycle”, “meiotic cell cycle process”, “rRNA metabolic process” and “ncRNA processing”, 
of which the top ten are listed in Table 5. Six gene sets were enriched in MII AD compared 
to GV, namely “mitotic nuclear division”, “organelle fission”, “cell proliferation”, “spindle”, 
“mitotic cell cycle” and “cell cycle”. Comparing MII control and MII AD, 18 gene sets were 
significantly enriched in MII but none was higher in MII AD. Among these set, the top five 
were “RNA processing”. “rRNA metabolic process”, “cytosolic ribosome”, “mRNA 
metabolic process” and “ribosomal subunit”. A summary of the results of the GSEA is shown 
in Figure 9, clustering the significantly enriched gene sets in both MII and MII AD compared 
to GV as well as of MII compared to MII AD under the corresponding collective term using 
REVIGO.  
GO ID Term 
Gene 
count FDR Proteins 
 
GO:0022402 
 
cell cycle process 
 
9 
 
0.0059 
 
CKS2, FLNA, ITGB1, NPM1, PRC1, 
PTTG1, TACC3, VRK1, WEE2 
 
GO:0007049 
 
cell cycle 
 
10 
 
0.0065 
 
CKS1B, CKS2, FLNA, ITGB1, NPM1, 
PRC1, PTTG1, TACC3, VRK1, WEE2
 
GO:0000278 
 
mitotic cell cycle 
 
7 
 
0.0133 
 
CKS2, FLNA, ITGB1, PRC1, TACC3, 
VRK1, WEE2 
  
GO:0000280 
 
nuclear division 
 
5 
 
0.0133 
 
CKS2, FLNA, PRC1, PTTG1, WEE2 
 
GO:0021943 
 
formation of radial 
glial scaffolds 
 
2 
 
0.0133 
 
FLNA, ITGB1 
 
GO:0050790 
 
regulation of 
catalytic activity 
 
12 
 
0.0133 
 
ATP1B1, CKS1B, CKS2, ITGA2, 
ITGB1, NPM1, PTTG1, SNCA, 
TCEA1, TMSB4X, TPM2, WEE2 
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GO:0051301 cell division 6 0.0133 CKS1B, CKS2, PRC1, PTTG1, 
TACC3, VRK1 
 
GO:0051336 
 
regulation of 
hydrolase activity 
 
9 
 
0.0133 
 
ATP1B1, ITGA2, ITGB1, NPM1, 
PTTG1, SNCA, TCEA1, TMSB4X, 
TPM2 
 
GO:0051726 
 
regulation of cell 
cycle 
 
9 
 
0.0133 
 
CKS1B, CKS2, ITGB1, NPM1, PRC1, 
PTTG1, RBBP7, TACC3, WEE2 
 
GO:0060700 
 
regulation of 
ribonuclease 
activity 
 
2 
 
0.0133 
 
NPM1, TCEA1 
 
GO:0065009 
 
regulation of 
molecular function 
 
14 
 
0.0133 
 
ATP1B1, CKS1B, CKS2, FLNA, 
ITGA2, ITGB1, NPM1, PLEKHG1, 
PTTG1, SNCA, TCEA1, TMSB4X, 
TPM2, WEE2 
 
GO:1904064 
 
positive regulation 
of cation 
transmembrane 
transport 
 
4 
 
0.0133 
 
ATP1B1, FLNA, SNCA, TMSB4X 
 
GO:1903047 
 
mitotic cell cycle 
process 
 
6 
 
0.0156 
 
CKS2, FLNA, ITGB1, PRC1, TACC3, 
VRK1 
 
GO:0043462 
 
regulation of 
ATPase activity 
 
3 
 
0.0187 
 
ATP1B1, TMSB4X, TPM2 
 
GO:0006996 
 
organelle 
organization 
 
13 
 
0.0197 
 
CKS2, FLNA, ITGB1, NPM1, PRC1, 
PTTG1, RBBP7, SNCA, TACC3, 
TMSB4X, TPM2, VRK1, WEE2 
Table 6: STRING analysis. Top 15 enriched biological functions according to STRING analysis of 
proteins with higher abundance in both MII control and MII AD compared to GV. 
 
Proteins with increased or decreased abundance in MII as well as in MII AD versus 
GV oocytes, were submitted to STRING analysis separately. Supplementary table 8 provides 
the significantly enriched biological processes the respective proteins are predominantly 
involved in. Additionally, the STRING network for proteins with higher abundance in the 
oocytes after IVM is presented in Figure 10 and the Top 15 enriched biological processes 
are listed in Table 6. Among the most significant terms are several cell cycle and cell division 
related processes, which includes e.g. WEE2, TACC3 or the cyclin-dependent kinases CKS2 
and CKS1B. Moreover, enriched terms with a high number of related proteins are e.g. 
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“regulation of metabolic process”, “regulation of gene expression” and “cellular component 
organization”. 
 
 
Figure 10 STRING network analysis of proteins with elevated abundance in both MII and MII AD 
oocytes compared to GV oocytes. Line strength indicates the level of confidence, which ranges from 
low (0.150) to highest (0.900). Node colors represent the related biological processes: red = cell 
cycle; blue = regulation of gene expression; green = cellular component organization and yellow = 
regulation of metabolic process. 
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4 Discussion 
Several studies conducted to examine oocyte maturation have described a large pool 
of stored transcripts and proteins and a strong decrease of transcription after the GV stage, 
and showed that transcription is active during in vitro maturation (24, 25, 28, 32). However, 
due to a broad variety of post-transcriptional and post-translational processes, transcriptomic 
approaches can provide only limited knowledge about the functional level of proteins. 
Therefore proteomic approaches are indispensable for a comprehensive molecular analysis 
in any biological system.  
While morphological and genetic aspects of oocyte maturation have been studied in 
detail since decades, the dynamic processes at the proteome level were not accessible until 
LC-MS/MS-based analytical methods and genome databases became available. The 
experiments described here address the question which proteins undergo quantitative 
changes during maturation. Given that the huge oocyte with 90 µm diameter contains a 
substantial amount of proteins (90 ng) and numerous stored transcripts, it is of special 
interest if de novo transcription is necessary for a successful maturation process, which 
individual proteins are dependent on de novo transcription and which are synthesized from 
stored mRNAs or pre-mRNAs. This discrimination can be performed by addition of the well-
established transcription inhibitor actinomycin D to the maturation medium. In addition, the 
approach described here also aims to identify and categorize proteins altered in abundance 
by proteolytic processes.  
4.1 Strategy and reproducibility of the proteomic analysis  
To address these questions, a holistic nano LC-MS/MS-based proteomic analysis of 
immature and in vitro matured oocytes was carried out. Beside MII oocytes matured 
according to the standard IVM protocol, oocytes matured in the presence of the transcription 
inhibitor ActD were analyzed. Oocytes that underwent this procedure are referred to as MII 
AD in this thesis, but it has to be considered that they do not possess the developmental 
capacity of normal MII oocytes (35). The presence of a polar body was assessed 
microscopically for each MII and MII AD oocyte to ensure their successful nuclear 
maturation. Thus, only biologically well characterized germ cells were subjected to the 
proteome analysis, which indicates successful nuclear maturation. However, cytoplasmic 
maturation may be disturbed, which is not evident from morphological observation. 
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For statistically powerful evaluation, eight biological replicates were analyzed per 
group and the complexity of the sample preparation, e.g. pre-fractionation or labelling, was 
reduced to ensure reproducibility. To minimize operational procedures in favor of 
reproducibility, oocytes were not denuded from the ZP prior to lysis and protein digestion, 
although the presence of very high abundant proteins from the zona pellucida (ZP) limits the 
attainable number of protein identifications due to the common problem of undersampling 
in LC-MS/MS analysis of complex samples. In addition, for a high degree of reproducibility, 
the straight-forward label-free quantification with the MaxQuant and Perseus platform was 
chosen for data analysis (56, 81), which is one of the most commonly applied software tools 
for label-free quantification.  
With this experimental strategy, 2018 proteins were identified across all samples. A 
number of proteomic studies targeting oocytes of different species with mass spectrometry-
based approaches revealed a broad range of protein IDs. For example, 3699 proteins were 
identified by Pfeiffer et al. (63) from 1884 murine MII oocytes, while Wang et al. (62) 
identified 2781 proteins in GV and 2973 proteins in MII oocytes from in total 7000 GV and 
MII oocytes and zygotes. In human, 2154 proteins have been identified by Virant-Klun et 
al. (65) in a proteomic approach starting from 100 oocytes, which were down-scaled to the 
level of single cells. In addition, 3765 proteins were identified by Chen et al (71) in a 
comparative proteomic analysis of GV and MII buffalo oocytes using iTRAQ-labelling of 
20 µg of protein combined with an in-gel-fractionation. In contrast, in the present study, the 
focus was on a reliable and reproducible analysis of proteomic changes during IVM and how 
these are affected by the absence of transcription, rather than on a high number of identified 
proteins. Nevertheless, the total number of protein IDs obtained here demonstrates that the 
analytical depth of the analysis was reasonably high.  
To gain insight into the reproducibility of the sample collection and also the sample 
processing, the overlap of identified proteins within the eight replicates of each group was 
evaluated. Several factors during oocyte collection and maturation lead to an increase of 
heterogeneity among the samples, which is inevitable when ovaries are obtained from 
abattoirs. Among these factors is a different oocyte quality caused by different stages of the 
estrous cycle, as well as age and genetic variations among the donor animals. Moreover, in 
vitro, approximately 90% of the oocytes undergo nuclear maturation, approximately 80% 
undergo fertilization, cleaving at least once and only about one third of the original pool of 
GV oocytes reaches the blastocyst stage after IVF (11), showing that despite successful 
nuclear maturation, the oocyte quality strongly varies even at the MII stage.  
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As shown in Figure 5B, the highest similarity among the replicates was seen in the GV 
oocytes with more than 90% of proteins detected in at least two replicates. Among the MII 
control oocytes, lower similarity with approximately 86% in a minimum of two replicates 
was found. This reflects the diversity in GV oocyte quality, which affects maturation, leading 
to a more diverse pool of MII oocytes. This effect is even more pronounced in the presence 
of the transcription inhibitor, where the comparatively low proportion of roughly half of the 
proteins was detected in each sample. This statistical finding indicates that, despite 
successful extrusion of the polar body, the maturation process is impaired through the 
inhibition of transcription.  
 
4.2 Oocyte maturation is reflected by substantial proteomic changes 
To assess the impact of inhibition of transcription during maturation in vitro on the 
oocyte proteome, first changes in the protein content during maturation were evaluated. 
Comparing the proteome of GV and MII oocytes, the dataset presented here demonstrates 
that IVM is associated with numerous significant changes in the quantitative protein 
composition. 294 proteins were found to be altered in abundance between the two groups, 
corresponding to 15% of all identified proteins, of which approximately half increased or 
decreased during maturation, respectively. This set of proteins comprises several proteins, 
which have previously been well described in the context of oocyte and early embryonic 
development, such as zygote arrest protein 1 (ZAR1), stathmin (STMN1), wee1-like protein 
kinase (WEE2) and vimentin (VIM). While ZAR1 and STMN1 were decreased after 
maturation, WEE2 and VIM are the proteins with the highest increase in abundance with a 
36-fold (WEE2) and a 22-fold increase (VIM) in the MII stage.  
Beside the identification of differentially abundant proteins, their affiliation to the 
biological processes and molecular functions associated with maturation were assessed using 
DAVID GO and gene set enrichment analysis. Proteins with decreased abundance in MII 
compared to GV oocytes were, among others, found to be related to the term “lysosome”. 
Lysosomes are important for embryogenesis and have been studied in mouse embryos: they 
increase after fertilization, stay abundant until the morula stage, after which they decrease 
(93). One protein within this cluster, lysosome-associated membrane glycoprotein 2 
(LAMP2), is 1.7-fold more abundant in GV oocytes compared to MII. It is a major 
component of the lysosomal membrane and essential for lysosomal biogenesis (94). 
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Knockdown of LAMP2 by injection of siRNA resulted in developmental retardation of 
embryos, even more pronounced when both LAMP1 and LAMP2 siRNA were injected (93).  
In both GSEA and DAVID analysis clusters related to translational initiation and RNA 
processing or binding were found to be enriched. Fig. 9 shows an overview of the enriched 
gene sets in MII compared to GV, clustered in superordinate terms. The DAVID GO analysis 
revealed that “RNA binding” is the cluster with the highest enrichment score in MII 
compared to GV. This is in good agreement with the literature, as for example Chen et al. 
(71) compared the proteome of GV oocytes and incompetent and competent MII oocytes 
and found that proteins related to the ribosome were among the proteins with higher 
expression in competent oocytes. In addition, they found a large number of proteins involved 
in mRNA processing and cell cycle and hypothesized that progression of the cell cycle might 
be driven by regulation of protein expression. It has previously been shown that large 
amounts of mRNA are synthesized and stored in the cytoplasm during maturation (25), and 
protein synthesis has been described to be essential for oocyte maturation and subsequent 
embryo development (15).  
Notably, the GSEA showed an enrichment of the gene sets “meiotic cell cycle process” 
and “meiotic cell cycle”. Proteins within these gene sets comprise, among others, WEE2, 
securin (PTTG1) and aurora kinase A (AURKA1). The serine/threonine kinase AURKA is 
involved in many processes essential for mitosis. It regulates centrosome migration and 
separation, followed by assembly of a bipolar spindle, trigger of mitotic entry, alignment of 
chromosomes in metaphase, cytokinesis and the return to G1 (95, 96). A substrate of 
AURKA is transforming acidic coiled-coil-containing protein 3 (TACC3), which supports 
the centrosome-dependent microtubule assembly in mitosis and which has also been found 
to be higher abundant in MII compared to GV with a 2.9-fold increase (97). Furthermore, 
the activation of the cyclin-dependent kinase 1 (CDK1)/cyclin B complex is also supported 
by AURKA (98). Thus, the holistic proteomic analysis of oocytes before and after 
maturation revealed several proteins important for IVM and their related biological 
processes. 
 
4.3 Maturation-associated proteins independent of de novo transcription 
To identify proteins and related biological processes independent of de novo 
transcription, proteins which are commonly increased or decreased after maturation 
irrespective of the presence of the transcription inhibitor were closely examined. In total, 75 
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proteins were found to be significantly altered in the comparisons of GV oocytes to both 
groups of oocytes after maturation, of which 34 were commonly decreased and 31 were 
commonly increased after maturation in MII and MII AD. Due to the low number of these 
proteins, DAVID GO analysis would not lead to a meaningful evaluation of associated 
cellular processes. Thus, both sets of proteins were submitted to STRING network analysis 
separately, to reveal biological processes these proteins are related to. Figure 10 graphically 
illustrates the results of the STRING analysis, clustering functionally related proteins. 
Proteins that are degraded during maturation were found to be predominantly related 
to reproduction-related GO terms, such as “sexual reproduction”, “reproductive process” and 
“single fertilization”, as shown in Supplemental Table 8. Within this cluster is YBX2, an 
oocyte-specific RNA-binding protein (99), which has been reported to have an important 
role in storage and translational regulation of maternal mRNAs during bovine in vitro 
embryogenesis (100). Its depletion results in a markedly perturbed oocyte growth and 
maturation (101) and leads to female sterility (102). In agreement with our data, YBX2 
protein levels were shown to decrease from the GV oocyte stage throughout development to 
the blastocyst stage (100).  
Besides YBX2, STMN1 and ZAR1 were also among the proteins with decreased 
abundance in both MII stage groups. ZAR1 and STMN1 have previously been described in 
the context of early embryonic development. ZAR1 is an oocyte specific maternal-effect 
gene involved in the oocyte-to-embryo transition and essential for female fertility (103). 
Maternal-effect genes are crucial for early cleavage regulation before the activation of the 
embryonic genome (104). STMN1, a substrate of CDK1, is a microtubule-destabilizing, 
cytosolic phosphoprotein involved in the construction of the mitotic spindle. A threshold 
level of STMN1 is required for progression through mitosis (105). It acts as a relay 
integrating diverse intracellular signaling pathways involved in regulation of cell 
proliferation, differentiation and function. A particular role for STMN1 at the successive 
steps of oocyte maturation and early embryonic development was suggested (106). 
In addition, STRING analysis showed an enrichment of the term “regulation of 
metabolic process” for both higher and lower abundant proteins after maturation. Proteins 
involved in different metabolic processes have also been shown to be differentially abundant 
in the comparisons of immature and mature buffalo and pig oocytes (45, 71). Metabolic 
pathways are indispensable for successful cytoplasmic maturation as the oocytes require 
different metabolites during the maturation process (15).  
 
Discussion   40 
 
On the other side, STRING analysis for the 31 proteins with an increase in abundance 
from GV to MII stage revealed an involvement of these proteins in cell-cycle-related 
processes. Within the GO term “cell cycle” are, among others, PTTG1, TACC3 and WEE2. 
The enrichment of these cell division-related proteins not only in the control but also in the 
ActD-treatment MII group indicates the transcription independent up-regulation of proteins 
necessary for meiotic cell division during maturation. Strikingly, WEE2, PTTG1 and 
TACC3 showed approximately the same ratio in MII and MII AD compared to GV. After 
maturation, WEE2 was 35.7 (MII control) and 35.4 (MII AD) times higher abundant in 
mature compared to GV oocytes, PTTG1 6.9- (MII control) and 7.3- (MII AD) fold higher 
and TACC3 2.9- (MII control) and 3.1- (MII AD) fold increased. Transcript levels of 
PTTG1, which plays a role in preventing chromosome segregation, were found to maintain 
high in porcine GV and MII oocytes compared to the zygote to blastocyst stages and also 
PTTG1 protein levels were shown to gradually decrease after fertilization (107). WEE2 is a 
downstream substrate of protein kinase A and known to be responsible for phosphorylation 
of the CDK1 inhibitory site, thereby maintaining meiotic arrest in oocytes (108, 109). High 
levels of WEE2 are probably needed for a tight control of the cell cycle during the upcoming 
cleavage cycles. In good agreement with our data, WEE2 has been found to be the protein 
with the highest increase in abundance during maturation in human oocytes (65). The very 
similar increase of these proteins independent of de novo transcription leads to the 
conclusion that mRNAs or pre-mRNAs for these proteins are already present in the oocyte 
prior to GVBD and subsequent maturation.  
Moreover, “cellular component organization” is among the enriched biological 
processes after maturation with or without transcription inhibitor. The related proteins are 
e.g. the integrins ITGA2 and ITGB1, PTTG and filamin-A (FLNA). As comprehensively 
reviewed by Ferreira et al. (15), cytoplasmic maturation is associated with ultrastructural 
changes and the redistribution of cytoplasmic organelles, such as the mitochondria or the 
ribosomes. The increase of proteins involved in this process indicates a reorganization of 
organelles not only in MII oocytes but also in the presence of ActD and therefore in the 
absence of transcription. 
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4.4 Identification and functional classification of de novo transcription-
dependent proteins 
Of particular interest are also proteins and related biological processes that require de 
novo transcription during maturation, e.g. proteins significantly increased after normal IVM, 
but not in the presence of ActD or to a clearly smaller extent.  
One of these proteins is vimentin (VIM), the protein with the second highest ratio after 
WEE2 in mature compared to immature oocytes. Although VIM is 22-fold increased after 
maturation without ActD, its abundance is not significantly altered in MII AD compared to 
GV oocytes. Therefore, the increase in abundance most likely relies on de novo transcription 
during maturation. In addition, VIM is, together with several histones, among the proteins 
with the highest abundance ratio in MII compared to MII AD oocytes. Vimentins are class-
III intermediate filaments attached to the nucleus, endoplasmic reticulum, and mitochondria 
(110) and a role for VIM in the attainment of genomic union during fertilization in mammals 
was suggested (111).  
DAVID GO analysis of the set of proteins, which were only increased in MII but not 
in MII AD compared to GV oocytes showed that “RNA binding” is the term with the highest 
enrichment score, which was also observed in the direct comparison of MII and MII AD 
oocytes. Moreover, a cluster containing the GO terms “translation” and “ribosome” was 
significantly enriched for these proteins. It has previously been shown that maternally 
transcribed mRNAs can be stored in the cytoplasm or in localized messenger 
ribonucleoprotein complexes in a translationally silent state during maturation (112). Until 
genome activation, the translational control of these transcripts is essential for properly timed 
oocyte development and maturation (113, 114). In previous publications, the high 
developmental capacity of oocytes was described to be related to their high rates of protein 
synthesis, and transcripts related to protein synthesis have been found to be higher abundant 
in competent oocytes (115, 116). Concomitantly, in their proteomic study of buffalo oocytes, 
Chen et al. (71) detected several ribosomal proteins with higher abundance in competent 
oocytes, indicating that the level of protein synthesis is related to the developmental 
competence. The higher abundance of ribosome-related proteins in MII compared to MII 
AD in the present study therefore leads to the hypothesis that inhibition of transcription leads 
to impaired protein synthesis, probably due to missing de novo transcripts and consequently 
reduced developmental competence of the resulting MII stage oocytes. 
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The cluster with the second highest enrichment score is “cell-cell adhesion”, a GO 
term that was also enriched in the direct comparisons of both MII groups to the GV group, 
which comprises, among others, FLNA. After maturation, FLNA was 7.2-fold higher in MII 
than in GV oocytes and had - despite transcription inhibition - a similar tendency, as it was 
found to be 4.3 times higher abundant in AD-treated MII oocytes compared to GV oocytes. 
This observation may lead to the hypothesis that novel transcription is partially required for 
the increase of FLNA levels. The different increase during maturation can be explained by 
the presence of transcripts for FLNA prior to the onset of maturation, supplemented by de 
novo transcription during IVM. Degradation of FLNA is promoted by filamin-A-interacting 
protein 1 (FILIP1), the protein with the strongest decrease in MII compared to GV oocytes. 
Phosphorylation of FLNA, an actin-binding protein that cross-links actin filaments, has been 
shown to be important for successful mitotic cell division (117). Moreover, it was found to 
control spindle migration and asymmetric division during oocyte meiosis through regulation 
of actin (118). Therefore the higher abundance of FLNA - and the lower abundance of 
FILIP1 - in both MII groups is likely to be related to the essential role of FLNA in cell 
division. 
 
Strikingly, a set of proteins was detected, which are altered in both MII and MII AD 
oocytes, but which showed opposite directions in treated and untreated MII oocytes. These 
proteins play a role in diverse mechanisms and processes which are impaired when 
transcription is inhibited during in vitro maturation of the oocyte.  
Six proteins were increased during normal, untreated in vitro maturation but decreased 
when transcription was inhibited during maturation. Alongside with the histones 
HIST1H2BI and HIST1H1C, these proteins include inositol-3-phosphate synthase 1 
(ISYNA1), tight junction protein 1 (TJP1), 60S ribosomal protein L22 (RPL22) and pterin-
4-alpha-carbinolamine dehydratase (PCBD1). The histone HIST1H2BI is the protein with 
the strongest abundance alteration in control versus AD-treated MII oocytes (30-fold). It is 
a member of the histone family H2B, which is, together with H1, H2A, H3 and H4, one of 
the five main histone proteins responsible for maintaining the structure of the nucleosome. 
In the present study, seven histones were detected among the set of abundance-altered 
proteins. In the comparison of GV and MII oocytes, all of them were more abundant after 
maturation. Strikingly, in the presence of AD only two histones – histone H1.2 and Histone 
H2B - were found to be altered in abundance, which showed approximately 3.5 times higher 
expression in GV than in MII oocytes, while they were also around 3.5-fold decreased in 
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MII AD compared to GV. Regarding control and AD-treated oocytes, besides HIST1H2BI 
seven more histones from all five histone families were significantly decreased in abundance 
in the treated group. As ActD is known to bind DNA at the transcription initiation complex 
consequently preventing elongation of the RNA chain by RNA polymerase (76), it 
apparently results in a strong degradation of certain histones during oocyte maturation. 
An interesting protein among the top five proteins higher abundant in control MII than 
in MII AD oocytes is PCBD1. It was found to be expressed in both mouse and Xenopus 
embryos from early specification onward. It is also a co-activator for hepatocyte nuclear 
factor 1-alpha (HNF1A)-dependent transcription and evidence was provided that PCBD1 
mutations can cause early-onset non-autoimmune diabetes (119, 120). 
 
Four proteins were found to be increased around 1.6-fold after maturation compared 
to GV despite ActD treatment, although they are decreased approximately 1.6- to 1.9-fold 
after untreated maturation. These are ADP/ATP translocase 1 (SLC25A4), protein S100-B, 
serine/threonine-protein phosphatase 2A activator (PTPA) and PITH domain-containing 
protein 1 (PITHD1), all of which are 2.5 to 2.9-fold increased in MII AD compared to MII 
control oocytes. There is only spatial knowledge about the role of these proteins in the 
context of oocyte maturation. However, SLC25A4 was identified among a set of 
polyadenylated transcripts that decreased in abundance during oocyte maturation and was 
ascribed to GO processes related to energy production. For all four proteins, the question 
arises, why their abundance increases when it is decreased after uninhibited maturation. A 
possible explanation is the degradation through proteases during normal IVM: if components 
of the proteolytic process require de novo transcription and are therefore not synthesized in 
the MII AD group, the level of the protease target proteins remains higher in MII AD 
oocytes. However, for an increase in abundance compared to GV, novel translation of these 
proteins is also required. This hypothesis is supported by the results of a DAVID GO of 
proteins higher abundant in the MII AD than in the MII control group. It revealed, among 
others, the enriched GO terms “nucleotide excision repair, DNA damage recognition” and 
“ubiquitin-dependent protein catabolic process”. In eukaryotic cells, the ubiquitin 
proteasome system is the main route for intracellular protein degradation (121). In a 
comprehensive review, Pomerantz and Dekel (122) discussed that several proteins involved 
in the regulation of the meiotic cell cycle, such as cyclin b, cdc25 and PTTG1 are degraded 
by the ubiquitin-proteasome system. Cyclin B1, which is known to dimerize with CDK1, 
one of the key regulators of meiosis, was found to be degraded by the proteasome prior to 
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cell division (17, 109, 123, 124). In addition, proteasomal degradation of PTTG1 was shown 
to be crucial for segregation of homologous chromosomes at anaphase I (125). Furthermore, 
it has been shown that inhibition of the ubiquitin proteasome pathway prevents the 
degradation of cyclin B1 and inhibits the extrusion of the second polar body (126). Huo et 
al. (126) therefore suggested a major role of the ubiquitin proteasome system in oocyte 
meiosis, the polar body extrusion and pronuclear formation by the regulation of cyclin B1 
degradation and phosphorylation of MAPK/p90rsk. In buffalo oocytes, several proteins 
related to the ubiquitin-proteasome proteolytic pathway were found to be higher expressed 
in competent compared to incompetent MII oocytes (71). Moreover, it has previously been 
shown that ubiquitin C-terminal hydrolase-L1 and the proteasome are involved in the first 
metaphase-to-anaphase transition of meiosis in porcine (67) and rat oocytes (127).  
In conclusion, the holistic proteomic analysis of immature and mature oocytes 
provides a comprehensive dataset of proteins and their related molecular functions during in 
vitro maturation. The events that occur during nuclear and cytoplasmic maturation were 
found to be strongly reflected on the proteome level, as major changes in the protein 
composition were detected after maturation. During maturation, protein synthesis and cell 
cycle-related proteins and processes were found to be increased. Furthermore, the effect of 
missing transcription on the proteome during in vitro maturation was examined. Addition of 
actinomycin D during maturation enabled the discovery of proteins either reliant on or 
independent of de novo transcription during maturation. While proteins related to translation 
and cell-cell adhesion were found to require de novo transcription, proteins independent of 
de novo transcription were assigned, among others, to cell cycle and metabolic processes, 
providing novel insight into in vitro maturation on the level of proteins. 
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5 Side project A: Proteomic analysis of uterine luminal fluid  
Original Article: Genetic merit for fertility affects the bovine uterine luminal 
fluid proteome 
 
The full article is presented on the following pages. The manuscript is accepted for 
publication at Biology of Reproduction. Supplementary information for this publication are 
accessible in the supplementary information.  
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1. Introduction 
A significant proportion of embryonic loss in dairy cows occurs quite early after 
conception. Some studies have indicated that up to 50% of embryos are lost prior to Day 7 
(128). Wiltbank et al. (129) described four pivotal periods for pregnancy loss during the first 
trimester of gestation in lactating dairy cows, each corresponding to key physiological 
changes in the embryo, uterine environment, and ovary. These are: (i) during the first week 
after breeding due to fertilization failure or death of the early embryo (20%-50%), (ii) from 
Days 8 to 27, encompassing conceptus elongation and maternal recognition of pregnancy 
with losses averaging ∼30%, but ranging from 25%-41%, (iii) from Days 28 to 60, with 
losses of ∼12%, and (iv) during the third month of pregnancy (∼2%). 
Single trait selection for milk production was highly effective in creating the modern 
high-yielding dairy cow. However, negative genetic correlations between production and 
fertility led to a progressive decline in dairy cow fertility (130-132). The causes of this 
subfertility are typically multifactorial and can be due to impacts at the level of the follicle 
and oocyte, the oviduct and early embryo or the uterus and later embryo/conceptus. The 
elucidation of the respective contributions of these various players to the reduced fertility in 
dairy cows associated with intensive selection for milk yield has been the subject of intense 
research efforts over several decades (133). With changes in weightings in selection indices, 
particularly involving a reduction in the weighting on milk production and an increase in the 
weighting on fertility, the decline in fertility has begun to be reversed (134). In addition, the 
intensive use of sophisticated ovulation synchronization protocols coupled with timed 
artificial insemination, particularly in US dairies, has dramatically improved fertility in 
recent years (135). Whether such protocols ultimately mask underlying fertility issues which 
would be manifest in the absence of such protocols is unclear. 
Using a model of Holstein cows with similar genetic merit for milk production traits, 
but with extremes of good (Fert+) or poor (Fert-) genetic merit for fertility traits, a series of 
recent studies analyzed the effects of genetic merit for fertility on phenotypic measures of 
fertility (136, 137). Compared with Fert- cows, those with good genetic merit for fertility 
had reduced incidence of clinical and subclinical endometritis (138), stronger expression of 
estrus (139), greater luteal phase progesterone (P4) concentrations (139, 140), and better 
coordination of corpus luteum (CL) and endometrium gene expression to support luteal P4 
synthesis and endometrial receptivity (141).  
The impact of genetic merit for fertility on the composition of uterine lumen fluid 
(ULF) has not been examined. After hatching from the zona pellucida, the ruminant 
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conceptus undergoes dramatic elongation and remains unattached in the uterine lumen for 
up to three weeks prior to initiation of implantation. This elongation process is driven by the 
maternal uterine environment as it does not occur in vitro or in the absence of uterine glands 
in vivo (142). To address the question of how the ULF promotes conceptus growth and 
development, analysis of ULF composition is essential. To date, the ULF proteome has been 
studied in several species including humans (143), sheep (144-146) and horses (147). In 
cattle, the ULF proteome has been examined in relation to P4 concentrations and the stage 
of the estrous cycle (148) as well as on Day 7 and Day 13 of the estrous cycle (149). 
Moreover, the ULF protein composition of Day 16 pregnant heifers and the proteome 
changes between Day 10 and 19 have been examined using a LC-MS/MS-based approach 
(150). Of interest, Faulkner et al. (151) compared ULF to blood plasma on Day 7 of the 
estrous cycle using iTRAQ-based proteomics to determine proteins with higher levels in 
ULF, which were, among others, related to stress and immune response as well as 
carbohydrate metabolism. 
All of the studies above were carried out in beef heifers, which have not been selected 
for milk yield. To our knowledge, the effect of genetic merit for fertility on the protein 
composition of the ULF in dairy animals has not been analyzed. To address this question, an 
animal model comprising three groups of early pregnant heifers differing in their estimated 
breeding value (EBV) for fertility, namely Holstein with low and high fertility as well as 
high fertility Montbéliarde, was established. Using nano -LC-MS/MS analysis combined 
with a label-free quantification approach, ULF from Day 19 of pregnancy was analyzed, 
which corresponds to the initiation of implantation, to identify quantitative proteome 
alterations associated with the genetic predisposition for fertility.   
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2. Materials and Methods  
All experimental procedures involving animals were licensed by the French Ministry 
for Schools, Higher Education and Research (reference number 02876.02), in accordance 
with the European Community Directive 2010/63/EU on the Protection of Animals used for 
Scientific Purposes. 
 
Animal management and ULF sampling 
Uterine luminal fluid was analyzed from three groups of heifers: Holstein heifers with 
low genetic merit for fertility (LFH, EBV for fertility - 0.31 ± 0.24), Holstein heifers with 
high genetic merit for fertility (HFH, EBV + 0.75 ± 0.18) and high fertility Montbéliarde 
heifers (MBD, EBV + 0.64 ± 0.20). 
The estrous cycles of all heifers were synchronized by insertion of a controlled 
intravaginal drug-releasing device (PRID DELTA, Ceva Santé Animale, Libourne, France) 
containing 1.55 g of P4, which was placed in situ for eight days. One day prior to PRID 
removal, each animal received a 2-ml intramuscular (i.m.) injection of a prostaglandin F2α 
analogue (PG: Estrumate, MSD Santé Animale, Beaucouzé, France) to regress the 
endogenous CL. All animals received a 2.5-ml i.m. injection of Receptal (MSD Santé 
Animale; equivalent to 0.012 mg buserelin) on the morning of Day 0. On Day 7 of the estrous 
cycle, each animal received one grade 1 late morula/early blastocyst stage embryo derived 
from superovulated and artificially inseminated MBD donors. Animals were slaughtered on 
Day 19 at a commercial abattoir and the reproductive tracts were collected within 30 min of 
knockdown. Each individual tract was stored on ice prior to sample collection. The uterine 
horns ipsilateral to the CL were flushed with 10 ml of phosphate buffered saline (PBS); 
pregnancy was confirmed by the presence of an elongated conceptus and the recovered flush 
volume was noted. The ULF was then clarified by centrifugation (1000 rpm for 10 min at 
4 °C) and snap frozen in 1 ml aliquots in liquid nitrogen and stored at -80 °C. For each of 
the three groups, four biological replicates, which stem from different animals, were 
analyzed. 
 
Sample preparation 
ULF samples were concentrated approximately 3 times using Amicon Centrifugal 
Filter Devices (Merck, Darmstadt, Germany) with a molecular weight cut-off of 3 kDa. 8 M 
urea / 0.4 M NH4HCO3 was added to the concentrated samples to a final concentration of 
approx. 7 M urea and samples were lysed by ultrasonicating twelve times for 10 sec 
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(Bandelin Sonopuls UW3200, Bandelin, Berlin, Germany). Pierce 660 nm Protein Assay 
(Thermo Scientific, Rockford, IL, USA) was used for protein quantification. Protein cysteine 
residues were reduced by addition of dithiothreitol to a final concentration of 5 mM 
dithiothreitol / 0.4 M NH4HCO3 at 37 °C for 30 min and subsequent alkylation in 15 mM 
iodoacetamide / 0.4 M NH4HCO3 for 30 min at room temperature in darkness. A trypsin/ 
lys-C mix (Trypsin/Lys-C Mix, Mass Spec Grade, Promega) was then added for digestion 
with a final protease to sample protein ratio (w/w) of 1:25 and incubated for 3 h at 37 °C 
followed by dilution to a final concentration of 1 M urea and overnight incubation at 37 °C. 
After addition of formic acid to a final concentration of 1%, the solution was dried using a 
vacuum concentrator and stored at -80 °C. 
 
LC-MS/MS analysis 
For analysis, samples were re-dissolved in 0.1% formic acid and separated on a 
PepMap C18 column (500 mm x 75 µm, 2 µm bead size, Thermo Scientific) using an EASY-
nLC 1000 system (Thermo Scientific, Rockford, IL, USA). The flow rate was set to 
200 nL/min and the gradient consisted of a first ramp to 25% B (100% acetonitrile, 0.1% 
FA) within 260 min and a second ramp to 50% B within 60 min. After separation, peptides 
were analyzed using a LTQ Orbitrap XL instrument (Thermo Scientific, Rockford, IL, 
USA), which was coupled online to the LC via liquid junction. Electrospray ionization was 
operated at a needle voltage of 1.9 kV and the MS was run in positive ion mode. Collision 
induced dissociation spectra were acquired using a collision energy of 35% and acquisition 
cycles consisted of one full MS scan and five subsequent data dependent MS/MS scans. 
 
Data processing 
MaxQuant (version 1.6.1.0) was used for processing the spectral data (Thermo RAW 
files) applying the implemented label-free quantification (LFQ) option (56). MS/MS spectra 
were searched against the bovine UniProt database (March 2018) using the Andromeda 
search engine to identify proteins with the ‘match between runs’ option enabled with a match 
time window of 0.7 min and an alignment time window of 20 min. For protein 
quantification, unique and razor peptides were used. Trypsin and Lys-C were chosen as 
enzymes with a maximum of two missed cleavages allowed. As fixed modification, 
carbamidomethylation was set and oxidation (M) was selected as variable modification. All 
other parameters were set according to MaxQuant default settings. For further analysis of 
the dataset, Perseus version 1.5.8.5 was used. After log2 transformation of LFQ intensities, 
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t-tests of pairwise comparisons between all groups were carried out. Proteins were 
considered as significantly altered in abundance with a t-test p-value of < 0.05 and a log2-
fold change of > |0.6|. 
 
Venn diagrams, gene ontology and gene set enrichment analysis 
The freely accessible online tools BioVenn (http://www.cmbi.ru.nl/cdd/biovenn/) and 
Venny 2.1 (http://bioinfogp.cnb.csic.es/tools/venny/) were used for creation of Venn 
diagrams (82). Functional annotation clustering (https://david.ncifcrf.gov) using the 
Database for Annotation, Visualization and Integrated Discovery (DAVID) was performed 
for the gene ontology (GO) terms “biological process”, “molecular function” and “cellular 
component” using the integrated Homo sapiens dataset as background (83-85). The human 
database was chosen as previously done by Faulkner et al., since it is better annotated than 
the Bos taurus database (148, 151).  
Gene clusters were considered as significantly enriched with an enrichment score of 
> 1.3. Significantly higher or lower abundant proteins were analyzed separately for each of 
the three pairwise comparisons. In addition, using the software GSEA v2.2.2 provided by 
the Broad Institute (http://software.broadinstitute.org/gsea) (86, 87), gene set enrichment 
analysis (GSEA) was carried out for each comparison between the groups. Therefore, LFQ 
intensities were loaded into the GSEA software and the following parameters were chosen: 
Number of permutations: 1000; Collapse dataset to gene symbols: false; Permutation type: 
gene set; Max size: exclude larger sets: 500; Min size: exclude smaller sets: 5. The following 
gene sets were chosen for analysis, which are provided by the Broad Institute: 
c2.cp.kegg.v5.1.symbols.gmt [Curated]; c5.bp.v5.1.symbols.gmt [Gene ontology]; 
c5.mf.v5.1.symbols.gmt [Gene ontology] and c5.cc.v6.2.symbols.gmt [Gene ontology]. 
GSEA default values were chosen for all other parameters. Gene sets were considered as 
significantly enriched with a FDR q-value of less than 0.05. 
For a summary and graphical illustration of the GSEA results, GSEA output for gene 
sets enriched in LFH compared to HFH and MBD, respectively, was submitted to REVIGO, 
an online tool accessible via http://revigo.irb.hr/ (88).  
Using the online tool Proteomaps (http://bionic-vis.biologie.uni-greifswald.de/), 
“Proteomaps” figures were generated from log2-transformed LFQ values of all significantly 
higher abundant proteins in LFH compared to HFH and/or MBD (152).  
  
Side project A   51 
 
3. Results 
To investigate the influence of the genetic predisposition for fertility on the protein 
composition of the ULF, a holistic proteomic approach using nano-LC-MS/MS analysis was 
carried out. A total of 1,737 proteins were identified across the three groups (LFH, HFH, 
MBD), while 1,120 proteins were commonly detected in each of the three groups, 
corresponding to 64.5% of all identified proteins (Figure 11A). The largest number of 
proteins uniquely detected in a single group was found in MBD (285 = 16.4%) followed by 
LFH (83 = 4.8%), while only 33 proteins were detected exclusively in HFH (= 1.9%).  
 
Figure 11: ( A) Venn diagram illustrating the overlap of the identified proteins within the three groups 
LFH, HFH and MBD. 1,120 proteins were detected in all of the three groups, while the highest number 
of proteins identified in a single group only were found in MBD. (B) Unsupervised hierarchical 
clustering and (C) principal component analysis. PCA and Hierarchical clustering of LFQ values 
show a clear separation of the low fertility index group LFH from both high fertility index groups HFH 
and MBD.  
Unsupervised clustering (Figure 11B) showed a clear discrimination of the low fertility 
group (LFH) from both groups with a high fertility index, whereas MBD and HFH were not 
clearly separated. Principal component analysis (PCA) shows a clear separation of the three 
groups, especially of LFH and the two groups with high genetic merit for fertility, while 
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MBD and HFH appeared to be more similar (Figure 11C). The variation among replicates 
was highest in LFH, intermediate in MBD, and smallest in the HFH group. 
 
Figure 12: Differentially abundant proteins in each of the three pairwise comparisons. (A) 
Number of differentially abundant proteins in each comparison. Blue and red segments of the bars 
represent the number of proteins with higher abundance in the group stated next to the bar. The vast 
majority of abundance-altered proteins is found between the low (LFH) and the high (HFH and MBD) 
fertility groups. (B)-(C) Volcano plots of the pairwise comparisons. Red spots in the volcano plots 
represent proteins that show lower abundance in the group that is named first with a log2-fold change 
< -0.6 and a t-test p-value < 0.05. Blue spots are assigned to proteins with a log2-fold change > 0.6 
that are more abundant in the first group compared to the second group. Indicated gene names refer 
to proteins elaborated in more detail in the discussion section. The respective protein spots are 
highlighted in the corresponding lighter colors. 
 
Using a label-free quantification approach, quantitative differences in protein 
abundances in pairwise comparisons were detected. In total, 597 proteins were significantly 
altered in abundance in all three comparisons, counting proteins only once if they were 
altered in several comparisons, corresponding to 34.4% of the total number of quantified 
proteins. The number of abundance-altered proteins for all three pairwise comparisons is 
shown in Figure 12A. Most abundance alterations were found comparing both high fertility 
groups MBD and HFH to the LFH group. The vast majority of abundance-altered proteins 
was detected comparing LFH and HFH (501) followed by LFH versus MBD (391), while 
only 56 abundance-altered proteins were detected between HFH and MBD. The volcano 
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plots in Figure 12B to D show the three pairwise comparisons, highlighting proteins of 
interest. A full list of all identified proteins as well as of abundance-altered proteins in each 
of the pairwise comparisons is provided in Supplementary tables 1 to 4 of Side project A. 
 
For functional classification of the obtained dataset, DAVID gene ontology and gene 
set enrichment analyses were carried out with the set of differentially abundant proteins for 
each of the three comparisons. Regarding the results obtained by the GSEA, gene sets were 
considered as significantly up-regulated with a false discovery rate (FDR) q-value of less 
than 0.05. For the comparison of LFH and HFH as well as LFH versus MBD, among the top 
20 gene sets higher in LFH were “lysosomal lumen”, “liposaccharide metabolic process”, 
“dicarboxylic acid metabolic process” and “extracellular space”. A summary of the results 
of the GSEA is shown in Figure 13B and C, clustering the significantly enriched gene sets 
in LFH compared to HFH and MBD, respectively, under the corresponding collective term 
using REVIGO. The complete lists of significantly enriched gene sets in the GSEA results 
are shown in the Supplementary tables 5 to 7 of Side project A. Among others, the gene sets 
“ribosome”, “rRNA metabolic process” and “protein targeting to membrane” were enriched 
in both MBD and HFH compared to LFH. The GSEA for the comparison of HFH to MBD 
resulted only in enriched gene sets for MBD, including “ribosomal subunit”, “cytosolic 
ribosome”, “rRNA metabolic process” and “ribosome”, but no significantly enriched gene 
set for proteins more abundant in HFH.  
The “Proteomap” shown in Figure 13A illustrates the processes to which the proteins 
that were significantly more abundant in LFH compared to either MBD or HFH or both are 
related. Using DAVID GO, the following GO terms and KEGG pathways were found to be 
significantly enriched (enrichment score > 1.3) for the abundance-altered proteins using the 
Homo sapiens database: In the comparison of LFH and HFH, terms with the highest 
enrichment scores for LFH were “lysosome”, “carbon metabolism”, “oxocarboxylic acid 
metabolism”, “nitrogen compound metabolic process” and “fatty acid beta-oxidation”. The 
enriched GO terms for the comparison of LFH and MBD were very similar to those of LFH 
versus HFH, except for “cysteine-type endopeptidase activity”, “glycosaminoglycan 
degradation”, “valine, leucine and isoleucine degradation” and “immune response”, which 
were higher in LFH. Regarding the comparison of HFH and LFH as well as MBD to LFH, 
proteins more abundant in the high fertility groups were found to be related, among others, 
to the GO terms “translation”, “cell-cell adhesion” and “protein transport”. DAVID GO 
analysis of the significantly altered proteins of the comparison of HFH and MBD resulted in 
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no significantly enriched term for HFH and two terms for MBD, namely “cytosol” and 
“nucleoplasm”. Supplementary tables 8 to 10 of Side project A show a complete list of the 
significantly enriched GO terms. 
 
Figure 13: Visualization of affected biological processes. (A) Visualization of proteins that are 
higher abundant in LFH compared to HFH and MBD and their related biological processes using 
Proteomaps shows an involvement of these proteins in several metabolic processes. The tiles of the 
Proteomap are arranged according to the hierarchical KEGG pathway maps. Related functional 
categories are clustered in adjacent regions with similar colors. Areas of tiles represent protein 
abundances, weighted by protein size. (B)-(C) Summary of the results of the GSEA. Enriched 
gene sets in LFH compared to HFH (B) and MBD (C) are clustered in superordinate GO terms using 
the tool REVIGO. For each set, the number of proteins is depicted in brackets. Identical bar colors 
correspond to the same umbrella terms stated below the bar. 
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4. Discussion 
Prior to implantation, which is initiated around Day 19 in cattle, growth of the 
conceptus is dependent on the constituents of the ULF. The impact of genetic merit for 
fertility on ULF composition has not been described. Therefore, ULF proteins from pregnant 
animals with different EBV for fertility were analyzed using a LC-MS/MS-based approach. 
As evident from other proteomic studies (143, 148, 153), the analysis of ULF proteome is 
especially challenging due to its high complexity including very high abundant proteins such 
as aldose reductase, cystatin or lactotransferrin. However, we identified 1,737 proteins, 
approximately two-thirds of which were shared between all three groups.  
 
Genetic merit for fertility outweighs the effect of breed on the ULF proteome 
To detect quantitative differences between the groups, a commonly-applied label-free 
quantification approach (56, 154) was used to determine proteins that were significantly 
altered in abundance. Among the set of detected proteins, 597 proteins were found to be 
differentially abundant in the comparisons within the different groups. As shown in Figure 
12, the vast majority of abundance-altered proteins was detected in the comparison of LFH 
and HFH, followed by LFH compared to MBD with 29% and 23% of all identified proteins 
significantly altered, respectively. Interestingly, in the pairwise comparison of MBD and 
HFH, both groups with a positive EBV, only 3% of the identified proteins were altered in 
abundance. This indicates a strong effect of the genetic predisposition for fertility on the 
ULF protein composition, since most alterations were detected between the high and low 
fertility Holstein groups. Furthermore, the effect of the different genetic backgrounds of the 
two breeds Montbéliarde and Holstein was clearly outweighed by the influence of their 
genetic merit for fertility, resulting in substantial differences in the ULF proteome. A clear 
separation of LFH and both high fertility groups is also shown in the unsupervised 
hierarchical clustering (Figure 11B), as well as in the PCA (Figure 11C), while MBD and 
HFH were not clearly separated in the hierarchical clustering and also appeared to be more 
closely related in the PCA. As proteome alterations between MBD and HFH related 
predominantly to genetic differences between the two breeds, we will focus in the following 
sections on the comparison of the low fertility group LFH to both high fertility groups HFH 
and MBD. A similar animal model has previously been analyzed in detail by Cummins et al. 
(136, 139, 155), investigating the impact of the genetic merit for fertility in Holstein cows. 
Their study comprised two groups of cows with similar proportions of Holstein genetics and 
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similar genetic merit for milk yield, but with either negative (good genetic merit for fertility; 
Fert+) or positive (poor genetic merit for fertility; Fert-) EBV for calving interval. They 
showed that Fert+ cows had higher daily milk yield, shorter calving to conception intervals, 
fewer services per cow and greater concentrations of circulating insulin, demonstrating a 
clear influence of the genetic merit for fertility on the reproductive performance. However, 
none of these papers addressed the effect of the genetic merit for fertility on uterine function. 
In contrast, the data presented here were obtained from an animal model specifically 
designed to facilitate the molecular analysis of diverse key reproductive tissues and fluids, 
such as those in the oviduct (156) and, in the current study, in the uterus, in correlation with 
the EBV of the animals. 
 
Genetic merit for fertility affects proteins related to metabolic processes 
Regarding the results of the DAVID GO analysis, in both comparisons - MBD vs. LFH 
and HFH vs. LFH - proteins more abundant in the ULF of high fertility heifers were found 
to be associated with the enriched GO terms “translation” and “cell-cell adhesion”. Similar 
results were obtained by the GSEA. Although a set of ribosomal proteins was also detected 
in the proteomic ULF studies by others (145-147, 149, 153, 157), their origin and role in 
ULF remains unclear.  
Given that the ULF in the current study was collected on Day 19 of pregnancy 
corresponding with the initiation of implantation in cattle, proteins involved in the GO term 
“cell-cell adhesion” may play a role in the attachment of the developing conceptus to the 
endometrium. Previously, transcriptomic studies of bovine endometrium have been 
conducted to elucidate mechanisms involved in the preparation of the endometrium for 
attachment and implantation of the embryo. The underlying processes during the 
preattachment period necessary for pregnancy recognition and implantation in ruminants has 
been comprehensively reviewed by Forde and Lonergan (158), Bauersachs and Wolf (159) 
and Sandra et al. (160). Along with several interferon-stimulated genes (ISGs), differentially 
expressed genes on Day 18 in endometrium of pregnant versus non-pregnant control animals 
were assigned to processes related to cell adhesion and endometrial remodeling (159, 161, 
162). Moreover, in a proteomic analysis of porcine endometrial tissue, Jalali et al. (163) 
showed that endometrial proteins with altered abundance on Day 12 in pregnant and non-
pregnant animals were, among others, related to growth and remodeling.  
Of particular interest, in our dataset one of the proteins with very high abundance 
alteration between high fertility and low fertility groups was sorbitol dehydrogenase (SORD) 
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with a 14.3- and 11.1-fold increase in HFH and MBD compared with LFH, respectively. 
SORD, which is known to be located in the extracellular space, is required for the conversion 
of glucose to fructose by oxidation of sorbitol and has been shown to be expressed in porcine 
uterine glandular and luminal epithelia during the peri-implantation period (164). Consistent 
with these observations, Simintiras et al. (165) described a 15-fold increase in 
mannitol/sorbitol in the ULF of heifers from Day 12 to 14, coinciding with the initiation of 
elongation, and a 29-fold increase in mannitol/sorbitol in the ULF on Day 12 in heifers with 
supplemented with P4 – a model known to accelerate conceptus elongation (166). Among 
the proteins with the most pronounced abundance alterations in HFH and MBD in 
comparison to LFH (8.7 and 6.7 times higher, respectively) was glutamine-fructose-6-
phosphate aminotransferase 1 (GFPT1), which also plays a role in glucose metabolism. 
GFPT1 is an enzyme of the hexosamine pathway catalyzing the formation of glucosamine 
6-phosphate. Both proteins have previously been detected in equine uterine fluid (167), as 
well as in human (SORD) (153) or ovine (GFPT1) (145) uterine fluid. The finding is in 
agreement with Forde et al. (150) who analyzed the ULF proteome in pregnant heifers, 
finding that fructose and mannose metabolism was among the overrepresented pathways on 
Day 16. 
Intriguingly, DAVID GO analysis of LFH comparisons to HFH and MBD revealed 
several significantly enriched GO terms associated with basic metabolic processes, such as 
“carbon metabolism”, “fatty acid metabolism” and “oxocarboxylic acid metabolism” 
(Supplementary tables 8 and 9 of Side project A). The results of the GSEA confirmed these 
findings, as a remarkable amount of gene sets enriched in LFH compared to MBD and HFH 
are related to metabolic and catabolic processes, such as “liposaccharide metabolic process”, 
“lipid catabolic process”, “organic acid catabolic process” and “dicarboxylic acid metabolic 
process” (Supplementary tables 5 and 6 of Side project A).  
The results of the gene set enrichment and DAVID GO analysis were confirmed using 
the Proteomaps tool (Fig 13A). As already evident from the DAVID GO analysis and the 
GSEA, the main process represented was “biosynthesis”, with the subordinate processes 
“amino acid metabolism”, “lipid and steroid metabolism” and “glycan metabolism”. 
Notably, the GSEA also showed that a considerable number of enriched gene sets in LFH 
compared to MBD and HFH were catabolic processes, indicating a disturbed metabolic 
condition of the animals within this group. Together with the previous finding that enzymes 
involved in glucose metabolism are more abundant in the high fertility groups, this hints at 
an impaired metabolism in animals with poorer genetic merit for fertility. 
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The data reported here are consistent with other studies analyzing ULF proteomes. For 
example, Forde et al. (150) found metabolic processes, including the GO terms “generation 
of precursor metabolites and energy” and “monosaccharide metabolic process”, to be 
overrepresented on Day 16 in pregnant vs cyclic heifers. It has also been shown that proteins 
involved in carbohydrate metabolism were more abundant during the early compared to the 
late luteal phase in beef heifers (148). This effect was ascribed to the adaptation of the uterus 
to the metabolic requirements of the embryo during the preimplantation period. The 
increased metabolic activity of the endometrium during pregnancy was also reflected in the 
findings of Ledgard et al. (168), who reported that proteins involved in biosynthetic 
pathways were more abundant in pregnant compared to non-pregnant cows. Moreover, it has 
been shown that proteins associated with carbohydrate metabolism are more abundant in 
uterine fluid compared to plasma, as embryonic growth is accompanied by changes in energy 
utilization and protein synthesis (151, 169, 170). In addition, the bovine embryo depends on 
the uterine environment until implantation to provide it with sufficient amounts of nutrients 
including amino acids, growth factors and ions (169).  
“Vitamin metabolic process” is one of the gene sets significantly enriched in the GSEA 
of LFH compared to both HFH and MBD. This gene set comprises, among others, folate 
receptor alpha (FOLR1) and legumain (LGMN), which have both been previously described 
in uterine fluid and/or endometrium. In LFH, FOLR1 was around four times more abundant 
compared to HFH and 10 times more abundant when compared to MBD. FOLR1 may play 
a role in the transfer of folate to the embryo, as it is well known that folate is essential during 
pregnancy due to its importance for DNA synthesis (171). It has been found to be more 
abundant in uterine fluid compared to plasma on Day 7 of the estrous cycle in beef heifers 
(151), hinting at an active regulation of this protein in ULF by the endometrium. In the 
present study, LGMN was found to be 5.0 times higher in LFH compared to HFH and MBD. 
The protease LGMN has been found to be more abundant on Day 13 compared to Day 7 of 
the estrous cycle in bovine histotroph (149) and its mRNA expression in the bovine 
endometrium was upregulated in the endometrium in the luteal phase and therefore 
concluded that it is controlled by P4 (168). In addition, they reported lower abundance of 
LGMN in ULF in non-pregnant compared to pregnant cows together with retinol-binding 
protein (RBP) and tissue inhibitor of matrix metalloproteinase 2 (TIMP2), both of which 
have also been found to be around five to six-fold more abundant in LFH compared to HFH 
as well as MBD. TIMP2 was also detected on Day 18 in pregnant and non-pregnant heifers 
Side project A   59 
 
by Ulbrich et al. (172), who suggested an involvement of TIMP2 in maternal recognition of 
pregnancy. 
LGMN is, together with chromogranin A (CHGA), also assigned to the lysosome and 
lysosomal lumen. Although lysosomes are intracellular organelles, serving as the cell’s 
digestive system, the GO term “lysosome” had the highest enrichment score in LFH 
compared to the two high fertility groups. Regarding the proteins assigned to this term, we 
found several proteins which were annotated as “extracellular region” or “extracellular 
space” or contained a signal peptide that allows the secretion through secretory vesicles 
(173), indicating that these proteins play a role in the uterine fluid. In addition to LGMN and 
CHGA, several cathepsins, e.g. CTSA, CTSL, CTSB and CTSZ, were among the lysosome 
related proteins in the GSEA and the DAVID GO analysis, which are also known to occur 
extracellularly. In a proteomic analysis of ULF performed by Forde et al. (150), the lysosome 
was also among the top KEGG pathways overrepresented in ULF on Day 16 in pregnant 
cows, comprising also legumain precursor as well as precursors of cathepsin B, D, S and Z. 
Besides their role in catabolism of intracellular proteins, the proteinases cathepsins are able 
to degrade proteins from the extracellular matrix and may regulate endometrial remodeling 
and conceptus implantation (174, 175). 
 
Alterations of immune system-related proteins are associated with a low 
fertility index 
 
Further evaluation of the set of abundance-altered proteins revealed that immune 
system-related GO terms, namely “immune response”, “adaptive immune response”, “innate 
immune response” and “complement and coagulation cascades” were enriched in LFH 
compared to HFH and MBD in both DAVID GO analysis and GSEA. Several studies have 
previously described that proteins associated with the immune system play a role in uterine 
fluid. In ewes, 22% of the identified proteins were related to the immune system and two of 
15 abundance-altered proteins between pregnant and non-pregnant animals were members 
of the complement component system, which plays a role in embryonic as well as host 
protection (144). Moreover, Forde et al. (150) found that proteins in the ULF from Day 16 
pregnant heifers were related with the GO terms “response to stimulus” and “complement 
and coagulation cascades” and concluded that this is related with the response to pregnancy 
recognition, as sufficient amounts of IFNT must be produced by about Day 16 to prevent 
luteolysis. Immune system-related proteins, e.g., lactotransferrin, have also been found to be 
increased in the uterus in ewes during the luteal phase of the estrous cycle (145). A study by 
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Faulkner et al (151), comparing uterine and plasma proteome of beef heifers on Day 7 of the 
estrous cycle, showed that predominant uterine proteins were also related to the immune 
system.  
It is well known that regulation of immune system processes during the peri-
implantation phase is a prerequisite for successful establishment of pregnancy. In human 
endometrial secretions prior to embryo transfer, Boomsma et al. (176) identified ten 
mediators of the immune system, among them four interleukins, macrophage inhibitory 
factor and tumor necrosis factor. Proteins involved in immune system-related processes were 
found to be more highly abundant in LFH compared to both HFH and MBD in our study, 
suggesting that animals with a low fertility index may suffer from a dysregulation of the 
defense response, possibly contributing to reduced fertility in this group. 
Among the proteins associated with the immune system are those exhibiting extreme 
abundance alterations, such as lactotransferrin (LTF), chromogranin A (CHGA) or 
tubulointerstitial nephritis antigen-like 1 (TINAGL1). LTF exhibited the highest difference 
in abundance with an 83-fold increase in LFH compared to HFH. In addition, it was among 
the five most abundant proteins in all ULF samples. LTF, an extracellular protein that is 
found in exocrine fluids, is an iron-binding protein with antimicrobial activity involved in 
the host defense. It has been detected in several studies analyzing bovine (151, 177), ovine 
(145, 147) as well as equine ULF (167).  
Similar to LTF, CHGA also has antimicrobial properties and is associated with 
immune system processes (178). It was 14-fold higher abundant in LFH compared to HFH 
and 17-fold increased compared to MBD. In addition to its antimicrobial function, CHGA 
has also been shown to play a role in regulating calcium and glucose metabolism (179). 
Using an LC-MS/MS-based proteomic approach, Mullen et al. (149) identified CHGA in 
bovine histotroph where it was found to be enriched on Day 13 compared to Day 7 of the 
estrous cycle, and hypothesized that CMGA in the uterus may also influence inflammatory 
pathways or regulate cell proliferation and metabolism at the embryo level. 
TINAGL1 is another extracellular protein that plays a role in the immune response and 
which was significantly altered in our study. It was found to be 13 times more abundant in 
LFH compared to HFH and 14-fold higher compared to MBD. Forde et al. (180) have 
previously shown that TINAGL1 showed minimal endometrial gene expression from Day 7 
to 13, when the uterus is not receptive, but increased on Day 16, especially in pregnant, but 
also in cyclic heifers (180). These authors concluded that endometrial TINALG1 plays a role 
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in implantation but is not directly involved in conceptus elongation. However, they failed to 
detect TINAGL1 protein in ULF. 
Of interest, interferon-tau variant 3h (IFNT) and interferon tau-2 (IFNT2) were both 
approximately 2- to 3-fold more abundant in LFH compared to HFH and MBD. Interferon 
tau is well known to be the primary pregnancy recognition signal in cattle (reviewed by 
Hansen et al. (181)). IFNT is secreted by the mononuclear trophectoderm cells of the 
conceptus, beginning at the blastocyst stage, increases during trophoblast elongation and 
declines during the peri-attachment period (182, 183). The secretion of sufficient amounts 
of IFNT is crucial to suppress luteolysis and maintain CL function, which is required for P4 
secretion and thus for growth and development of the conceptus (184, 185). It has been 
shown by microarray analyses that ISGs together with immune response-related genes were 
within the top up-regulated gene sets in Day 17 pregnant compared to non-pregnant cows 
(186). Successful establishment of pregnancy requires a balance of pro- and anti-
inflammatory molecules to ensure functionality of the maternal immune system against 
pathogens and simultaneously preventing a rejection of the conceptus, which can be regarded 
as a semi-allograft. Accordingly, Bauersachs et al. (161) showed that transcript levels of 
genes involved in the modulation of the maternal immune system were elevated in 
endometrium samples from Day 18 pregnant compared to non-pregnant heifers. Among the 
mRNAs with higher abundance were also several that are induced by interferons. Thus, 
insufficient IFNT secretion and consequently compromised IFNT signaling are therefore 
likely to lead to deficiencies during pregnancy recognition and subsequent implantation of 
the conceptus into the uterus. Insufficient IFNT secretion might result from a decreased 
conceptus size or from impaired endometrial secretion.  
 
In conclusion, results of this study demonstrate a major impact of the EBV for fertility 
on the quantitative protein profile of ULF. Most interestingly, differences in the genetic 
background of the two breeds studied – Montbéliarde and Holstein – are far less pronounced 
than the influence of the fertility status, since the vast majority of altered proteins was 
detected between low and high fertility groups, irrespective of breed. We found an increase 
of proteins related to metabolic processes, supporting the hypothesis that a disturbed 
metabolism in the uterus may affect reproductive success. Moreover, a large number of 
abundance alterations were found to be associated with the immune response in the low 
fertility group, suggesting an involvement of the immune system in the impaired fertility in 
such animals. 
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Abstract
The oviduct plays a crucial role in fertilization and early embryo development providing the
microenvironment for oocyte, spermatozoa, and early embryo. Since dairy cow fertility declined
steadily over the last decades, reasons for early embryonic loss have gained increasing interest.
Analyzing two animal models, this study aimed to investigate the impact of genetic predisposition
for fertility and of metabolic stress on the protein composition of oviduct fluid. A metabolic model
comprised maiden Holstein heifers and postpartum lactating (Lact) and non-lactating (Dry) cows,
while a genetic model consisted of heifers from the Montbéliarde breed and Holstein heifers with
low- and high-fertility index. In a holistic proteomic analysis of oviduct fluid from all groups using
nano-liquid chromatography tandem-mass spectrometry analysis and label-free quantification, we
were able to identify 1976 proteins, among which 143 showed abundance alterations in the pairwise
comparisons within both models. Most differentially abundant proteins were revealed between
low fertility Holstein and Montbéliarde (52) in the genetic model and between lactating and maiden
Holstein (19) in the metabolic model, demonstrating a substantial effect of genetic predisposition
for fertility and metabolic stress on the oviduct fluid proteome. Functional classification of affected
proteins revealed actin binding, translation, and immune system processes as prominent gene
ontology (GO) clusters. Notably, Actin-related protein 2/3 complex subunit 1B and the three
immune system-related proteins SERPIND1 protein, immunoglobulin kappa locus protein, and
Alpha-1-acid glycoprotein were affected in both models, suggesting that abundance changes of
immune-related proteins in oviduct fluid play an important role for early embryonic loss.
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Summary Sentence
Protein composition of oviduct fluid—the natural environment for the early embryo—depends
on metabolic status and genetic predisposition of dairy cows, affecting, among others, proteins
related to immune response.
Key words: domestic animal reproduction, early development, fallopian tubes, female reproductive tract, fertility,
oviduct, proteomics, ruminants.
Introduction
The oviduct provides a unique environment in terms of metabolites,
proteins, steroid hormones, and ions [1–5]. Several crucial steps for
successful pregnancy establishment occur in the oviduct. Initially,
the oviduct captures the oocyte at ovulation, transports, selects and
stores the sperms, and regulates fertilization. Following fertilization,
the first mitotic cleavage divisions also occur in the oviduct, the
timing of which has consequences for the developmental potential of
the embryo [6]. Furthermore, the switch from maternal to embryonic
control of development, so-called embryonic genome activation [7,
8], occurs at the 8- to 16-cell stage in cattle between 3 and 4 days
after fertilization when the embryo is still in the oviduct. Thus, there
is a significant potential for the oviduct environment to influence the
development of the embryo as it passes through its way to the uterus.
Indeed, significant evidence exists demonstrating a positive effect
of oviduct secretions on the embryo. While it is possible to produce
embryos in vitro, the quality of the embryos produced is significantly
lower than those derived in vivo, as evidenced by differences in
morphology, gene expression signatures, and cryotolerance [9, 10].
Developing in vitro produced embryos transiently in the sheep
oviduct [11] or in vitro in the presence of bovine oviduct epithelial
cells (BOEC) has been shown to improve their quality [12].
To understand how the oviduct fluid (OF) influences the gametes,
the process of fertilization and the early embryonic development,
insight into the proteomic profile of the OF is a prerequisite. The
technical evolution of liquid chromatography tandem-mass spec-
trometry (LC-MS/MS)-based proteomics enables an increasingly
comprehensive analysis of OF protein composition.
The bovine OF proteome has been analyzed in relation to the
stage of the estrous cycle and the location relative to the corpus
luteum (CL) [4]; differentially expressed proteins were mainly associ-
ated with cellular and metabolic processes. Another study analyzing
the secretome of in vivo and in vitro cultured BOECs reported
that the majority of secreted proteins are growth factors, metabolic
regulators, enzymes, immune modulators, and extracellular matrix
components [13]. Functional analysis of the proteins revealed an
involvement in immune homeostasis, gamete maturation, fertiliza-
tion, and the early embryonic development. In addition, several
studies have been carried out showing that the composition of OF is
dynamic and undergoes constant change depending on the stage of
the cycle or the presence of gametes, zygotes, or early embryos [14–
16]. A comprehensive overview of these studies was given by Maillo
et al. [17]. However, data on the effects of lactation or genetic fertility
index on the composition of OF are currently lacking.
The physiological changes associated with high milk production
are related to poor reproductive efficiency in commercial dairy
herds. Decreasing levels of glucose, insulin, and Insulin-like growth
factor 1 (IGF1) or increasing levels of non-esterified fatty acids
(NEFA) and ketone bodies circulating during nutrient partitioning
are associated with low body condition score (BCS) and undoubt-
edly play a role in determining reproductive outcome. However,
understanding the causes of infertility in dairy cattle is complex and
may also be attributable to compromised oocyte quality and/or a
suboptimal reproductive tract environment incapable of supporting
normal embryo/conceptus development or a combination of both.
Furthermore, genetic effects on physiological characteristics influ-
encing fertility have been well described [18–20].
Interestingly, data from nonsurgical flushing of single-ovulating
high-producing dairy cows indicate that about 50% of embryos
degenerate by Day 7 after breeding, that is, shortly after leaving
the oviduct [21, 22]. Furthermore, embryo development to Day 7
following endoscopic transfer of in vitro produced 3–4-cell embryos
into the oviducts of postpartum lactating cows was compromised
in comparison with that in the tract of nulliparous heifers [23].
More recently, age-matched postpartum primiparous dairy cows that
were either milked post calving (i.e., lactating) or were dried off
immediately at calving (i.e., non-lactating) were used to directly
test the effects of lactation on postpartum fertility characteristics
[24]. Consistent with the results of Rizos et al. [25], development
to blastocyst was reduced after embryo transfer to the oviducts of
lactating cows compared with non-lactating cows or heifers [24],
suggesting an impaired oviduct environment due to the metabolic
stress associated with lactation.
In this study, we hypothesized that differences in fertility are
in part due to metabolic status (heifers vs. non-lactating vs. lac-
tating cows) and genetic merit for fertility (high vs. low fertility
heifers). Furthermore, we hypothesized that differences in the com-
position of OF are associated with a compromised ability to support
early embryo development. We have previously characterized the
metabolic status of age-matched postpartum primiparous dairy cows
that were either lactating or non-lactating as well as a contem-
poraneous group of non-pregnant heifers [26]. Thus, two animal
models were established, each comprising three groups of animals
that differed on the one hand in their level of metabolic stress and
on the other hand in their fertility index. In a subset of animals from
each group, we collected OF on Day 3 of a synchronized estrous cycle
and performed quantitative protein profiling using nano-LC-MS/MS
in order to identify protein abundance changes associated with the
reduced early embryo survival in lactating cows.
Materials and methods
All experimental procedures involving animals were sanctioned
by the Institutional Animal Research Ethics Committee and were
licensed in accordance with Statutory Instrument No. 543 of 2012
under Directive 2010/63/EU on the Protection of Animals used for
Scientific Purposes.
Animals and oviduct fluid collection
Oviduct fluid from two different animal models was analyzed.
The metabolic model, consisting of maiden Holstein (MH)-Friesian
heifers and postpartum lactating (Lact) and non-lactating (Dry)
Holstein-Friesian cows, has previously been described in detail
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[27]. In short, in-calf primiparous Holstein-Friesian heifers and
non-pregnant Holstein-Friesian heifers with a similar economic
breeding index (EBI = 140.6e ± 20.4e) were enrolled into the
study. At calving, cows were randomly assigned to one of the two
groups, lactating or non-lactating. From calving, animals in the
lactating group were milked twice a day (07:00 and 16:00 h), while
those in the non-lactating group were dried off immediately after
calving (i.e., never milked).
The genetic model comprised low fertility Holstein (LFH) heifers
with an estimated breeding value (EBV) for heifer’s fertility of
−0.31 ± 0.24, high fertility Holstein (HFH) heifers with an EBV of
+0.75 ± 0.18, and French Montbéliarde (MBD) heifers with an EBV
for reproduction of +0.64 ± 0.20. The estrous cycles of all animals
were synchronized using a controlled intravaginal drug device (PRID
DELTA, Ceva Santé Animale, Libourne, France) containing 1.55 g
of progesterone (P4) inserted for eight days. One day prior to PRID
DELTA removal, each animal received a 2-ml intramuscular injection
(i.m.) of a prostaglandin F2α analog (PG: Estrumate, MSD Santé
Animale—Intervet, Beaucouzé, France; equivalent to 0.5 mg clo-
prosténol) to regress the endogenous CL. Animals were observed and
monitored for estrus behavior (Day 0). All animals were slaughtered
in a commercial abattoir on Day 3 after estrus. The oviducts were
cleaned of surrounding tissues, separated at the isthmus/ampulla
junction, and 500 μl of phosphate buffered saline (10 mM phos-
phate buffer, 2.7 mM potassium chloride, 137 mM sodium chloride,
pH 7.4) was injected into the isthmic part of the oviduct. Oviduct
fluid was then collected by gentle pressing of the oviduct. Oviductal
cells were separated from the OF by centrifugation at 200g for
10 min and the supernatants were then centrifuged at 12 000g for
10 min. The remaining supernatants were collected and stored at
−80 ◦C. Four biological replicates per group were analyzed for the
genetic model and five for the metabolic model.
Sample preparation
Oviduct fluid samples were dried using a vacuum concentrator.
Lyophilisates were redissolved in 8 M urea/0.4 M NH4HCO3 and
ultrasonicated 12 times for 10 s (Bandelin Sonopuls UW3200,
Bandelin, Berlin, Germany). Protein amounts were quantified using
Pierce 660 nm Protein Assay (Thermo Scientific, Rockford, IL,
USA). Samples were prepared for LC-MS/MS analysis by reduc-
tion of cysteine residues during 30 min of incubation in 5 mM
dithiothreitol/0.4 M NH4HCO3 at 37 ◦C, followed by alkylation
in 15 mM iodoacetamide/0.4 M NH4HCO3 for 30 min at room
temperature in darkness. For enzymatic digestion, a Trypsin/Lysyl
endopeptidase (Lys-C) mix (Mass Spec Grade, Promega) was added
with a final protease to sample ratio (w/w) of 1:25 and incubated
for 3 h at 37 ◦C to perform the Lys-C reaction. To facilitate trypsin
digestion, samples were diluted to a final concentration of 1 M urea
and incubated overnight at 37 ◦C. Formic acid (FA) was added to
a final concentration of 0.6% and the solution subsequently dried
using a vacuum concentrator.
Liquid chromatography tandem-mass
spectrometry analysis
Digested protein samples were redissolved in 0.1% FA and separated
using an EASY-nLC 1000 system (Thermo Scientific, Rockford, IL,
USA), and a PepMap C18 column (500 mm × 75 μm, 2 μm bead
size, Thermo Scientific) at a constant flow rate of 200 nl/min. The
gradient consisted of a ramp to 25% B (100% acetonitrile, 0.1% FA)
within 320 min and a second ramp to 50% B within 120 min in the
case of the samples from the energy balance model. Samples from the
genetic merit model were separated using a time-optimized gradient
with a ramp to 25% B within 260 min and a second ramp to 50% B
within 60 min. The chromatographic system was coupled online to
an LTQ Orbitrap XL instrument (Thermo Scientific, Rockford, IL,
USA) via liquid junction. The mass spectrometer was run in positive
ion mode and the electrospray ionization was operated at a needle
voltage of 1.9 kV. For data acquisition, collision-induced dissociation
spectra were acquired using a collision energy of 35%. Acquisition
cycles consisted of one full MS scan followed by five data dependent
MS/MS scans.
Data processing
Spectral data (Thermo RAW files) were processed using MaxQuant
version 1.5.2.8 and the implemented label-free quantification
(LFQ) option [28]. For protein identification, MS/MS spectra were
searched against the bovine UniProt database (July 2015) using the
Andromeda search engine. The “match between runs” option was
enabled with a match time window of 0.7 min and an alignment time
window of 20 min. Unique and razor peptides were used for protein
quantification. Trypsin and Lys-C were chosen as enzyme with
maximum of two missed cleavages allowed. Carbamidomethylation
was selected as fixed modification and oxidation (M) was used as
variable modification. All other parameters were set according to
MaxQuant default settings.
Further data analysis was performed using Perseus version
1.5.1.6. Label-free quantification intensities of precursor ions were
log2 transformed and t-tests of pairwise comparisons between all
groups within the metabolic and the genetic model were carried out.
Proteins were considered as significantly altered in abundance with
a t-test P-value of less than 0.05 and a log2-fold change of >|0.6|.
Venn diagrams, gene ontology, and gene set
enrichment analysis
Venn diagrams were created using the freely accessible web appli-
cation BioVenn provided on http://www.biovenn.nl/ [29]. Database
for Annotation, Visualization and Integrated Discovery (DAVID)
functional annotation clustering (https://david.ncifcrf.gov) was per-
formed with all 143 proteins which exhibited significantly altered
abundance for the GO terms “biological process,” “molecular func-
tion,” and “cellular component” using the integrated Bos taurus
dataset as background [30–32]. Gene clusters of related biological
functions showing an enrichment score above 1.3 were considered
as relevant. Since in the metabolic model the overall number of
proteins showing abundance alterations was not sufficiently large for
meaningful annotation clustering, abundance-altered proteins from
the metabolic model and the genetic model were pooled for this
analysis.
Gene set enrichment analysis (GSEA) was carried out using
the software GSEA v2.2.2 provided by the Broad Institute (http://
software.broadinstitute.org/gsea/) [33, 34]. Label-free quantification
intensities of all proteins identified in the two groups of the respective
pairwise comparison were loaded into the GSEA software and the
following parameters were set: number of permutations: 1000; col-
lapse dataset to gene symbols: false; permutation type: gene set; max
size: exclude larger sets: 500; and min size: exclude smaller sets: 5.
As GSEA is based on LFQ values of the identified proteins, it is only
applicable to pairwise comparisons and was therefore performed for
all groups within each of the two models.
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Figure 1. Venn Diagram showing the overlap of the quantified proteins within
the four replicates of the LFH group. About 67.4% of all proteins were found in
every replicate of the LFH group and less than 5% were detected exclusively
in one replicate showing good conformance of the samples and the sample
generation.
Among the databases provided by the Broad Institute, the follow-
ing gene sets were chosen for analysis: c2.cp.kegg.v5.1.symbols.gmt
[Curated]; c5.bp.v5.1.symbols.gmt [Gene ontology]; and
c5.mf.v5.1.symbols.gmt [Gene ontology]. All other parameters were
set to GSEA default values. Gene sets with a false discovery rate
(FDR) q-value of less than 0.05 were considered as significant.
“Proteomaps” graphics were generated from log2-transformed
LFQ values of all significantly altered proteins using the online tool
Proteomaps (http://bionic-vis.biologie.uni-greifswald.de/) [35].
For prediction of signal peptide cleavage sites, FASTA sequences
of the proteins of interest were submitted to the SignalP 4.1 server,
accessible via http://www.cbs.dtu.dk/services/SignalP/. A default D-
cutoff value of 0.45 was applied [36].
Results
A total of 1622 proteins (FDR < 1%, two individual peptides) were
identified in the OF from the isthmus ipsilateral to the CL from all
samples of the genetic model. To get insight into the reproducibility
of the proteomic analysis as well as of the sample generation, we
examined the distribution of the identified proteins within the four
biological replicates of each group. As an example, a Venn diagram
of the four replicates of the LFH group with the relative number of
identified proteins is shown in Figure 1. In each of the four biological
replicates, less than 5% of the proteins were detected exclusively in
the respective sample. The vast majority (almost 87%) of all proteins
was identified in at least two replicates, while 876 proteins (67.4%)
were found in each replicate.
The Venn diagram in Figure 2A shows the distribution of the
identified proteins among the three groups MBD, LFH, and HFH.
A total of 1058 proteins (65.1%) were found in all three groups. Of
the total proteins, 5.9% (95 proteins) were solely found in the HFH
samples and 5.7% (92 proteins) solely in the LFH group, while the
highest fraction of proteins identified exclusively in a single group
(12.9%, 209 proteins) was detected in the MBD group. A principal
component analysis (PCA) of all replicates of the genetic model is
shown in Figure 3. The OF samples of the LFH group clustered
separately from those of the HFH group. In contrast, the MBD
samples showed a larger within group heterogeneity and partially
overlap with the LFH group. A list of all identified proteins in the
genetic model is provided in Supplementary Table S9.
From all OF samples taken from the isthmus ipsilateral to the
CL in the metabolic model, 1572 proteins were identified in total,
which are listed in Supplementary Table S8. The distribution of all
proteins among the three groups of the metabolic model is shown
in Figure 2B. A total of 1061 proteins (67.5%) were detected in all
groups. The majority (74.9%) of the identified proteins were shared
between at least two groups: 2.7% (42 proteins) were detected solely
in the MH group and 4.8% (75 proteins) in the Dry group, while the
Lact group showed the highest proportion (17.6%, 277 proteins).
To identify quantitative differences in the abundance of individ-
ual proteins, the LFQ values of the MaxQuant software were used.
The total numbers of proteins showing abundance differences are
depicted in Figure 4.
In the metabolic model, we found a total of 37 significantly
(P-value < 0.05, log2-fold change >|0.6|) altered proteins in all,
counting proteins altered in multiple comparisons only once, which
corresponds to 2.4% of the identified proteins within this model.
Regarding the three comparisons between Lact, Dry, and MH, we
detected the highest number (19) of significantly altered proteins
between MH and Lact. Comparing MH and Dry, 13 proteins differed
in abundance and 12 proteins were changed between Lact and Dry.
Among the comparisons within the genetic model, in total
110 different proteins were significantly (P-value < 0.05, log2-
fold change >|0.6|) altered in abundance in any of the pairwise
comparisons (Figure 4). Most differences were detected between
LFH and MBD (52), followed by HFH versus MBD (47) and LFH
compared with HFH (37). For each of the six pairwise comparisons,
proteins IDs, log2-fold changes, and t-test P-values are listed in
Supplementary Tables S2–S7.
In general, for all pairwise comparisons, the number of proteins
showing abundance alterations was higher in the genetic merit model
than in the metabolic disturbance model. The comparisons in the
genetic model as well as in the metabolic model are illustrated in the
Volcano plots in Figure 5. Proteins are plotted by their t-test P-value
and their log2-fold change.
Notably, we also found four proteins that were significantly
altered in pairwise comparisons of the genetic as well as of the
metabolic model, which are listed in Table 1.
For functional characterization of affected OF proteins, we per-
formed a DAVID gene ontology analysis using the term “cellular
component” as shown in Table 2. In addition to the GO terms “cell
projection” and “non-membrane-bounded organelle”, the cluster
“extracellular region” was also enriched (enrichment score of 1.9).
To complement the results obtained by the DAVID GO cellular
component analysis, a SignalP 4.1 analysis was performed for those
proteins with altered abundance as well as the entire set of identified
proteins. SignalP unveils proteins containing a signal peptide that
allows the secretion by secretory vesicles via the endoplasmic reticu-
lum and Golgi apparatus [37]. Analysis of all differentially abundant
proteins in both the genetic and the metabolic model revealed that
22% of the proteins (31/143) contain a signal peptide and are
therefore very likely to be secreted into the oviduct. These proteins
are listed in Table 3. Regarding all identified proteins, 274 out of
1976 proteins were found to contain a signal peptide, corresponding
to 14% of the proteins.
For a comprehensive analysis of the dataset, a GSEA was
performed for every pairwise comparison within each model using
the gene set databases KEGG (Kyoto Encyclopedia of Genes and
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Figure 2. Venn diagrams of identified proteins from (A) the metabolic model and (B) the genetic model sorted by their corresponding groups. In both models,
almost 1100 proteins were detected in all three groups. The highest number of proteins identified in only one of the groups was found in the lactating (metabolic
model) and the MBD group (genetic model). The abundance of these proteins may have been below the detection limit and therefore they cannot be regarded
as absent in the other groups.
Table 1. Proteins significantly altered in both the energy balance and the genetic model (see text for details).
UniProt accession Gene name Protein name Comparison Ratio P-value
Q5GN72 AGP Alpha-1-acid glycoprotein Lact vs. MH 2.06 0.041
LFH vs. MBD 0.29 0.031
F1MZ96 N/A IGK protein Dry vs. MH 1.97 0.044
LFH vs. MBD 0.28 0.015
Q58CQ2 ARPC1B Actin-related protein 2/3
complex subunit 1B
Lact vs. MH 1.65 0.042
LFH vs. MBD 0.60 0.029
A6QPP2 SERPIND1 SERPIND1 protein Lact vs. MH 1.91 0.004
HFH vs. MBD 0.33 0.020
LFH vs. MBD 0.33 0.029
MH: Maiden heifer; Lact: postpartum lactating cows; Dry: postpartum non-lactating cows; LFH: Low fertility heifer; HFH: High fertility heifer; and MBD: Montbéliarde heifer.
Figure 3. Principal component analysis of all biological replicates of the
genetic model. In the genetic model, the PCA of all replicates of the three
groups HFH, LFH, and MBD shows clear discrimination between the HFH and
the LFH group.
Figure 4. Number of differentially abundant proteins in each of the six
pairwise comparisons. Green bars represent the number of proteins that
are higher abundant in the group named first in the legend below the bar,
while red bars show the number of proteins that are decreased in abundance
compared with the second group.
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Figure 5. Volcano plots. Volcano plots of pairwise comparisons of (A) the genetic model and (B) the metabolic model. Red spots in the volcano plots represent
proteins that show lower abundance in the group that is named first with a log2-fold change < −0.6 and a t-test P-value < 0.05. Green spots are assigned to
proteins with a log2-fold change > 0.6 that are more abundant in the first group compared with the second group.
Table 2. Enriched annotation cluster from the DAVID GO analysis of abundance-altered proteins from both models according to the term
“cellular component.”
Annotation cluster 1 enrichment score: 3.23 Cell projection
Term % P-value Fold enrichment
GO:0042995∼cell projection 9.2 2.02E-04 4.7
GO:0031252∼cell leading edge 4.6 9.87E-04 11.0
GO:0001726∼ruffle 3.7 1.05E-03 19.2
Annotation cluster 2 enrichment score: 2.57 Non-membrane-bounded organelle
Term % P-value Fold enrichment
GO:0005856∼cytoskeleton 12.8 2.15E-03 2.6
GO:0043232∼intracellular non-membrane-bounded organelle 19.3 3.01E-03 1.9
GO:0043228∼non-membrane-bounded organelle 19.3 3.01E-03 1.9
Annotation cluster 3 enrichment score: 1.90 Extracellular region
Term % P-value Fold enrichment
GO:0042627∼chylomicron 2.8 1.26E-03 52.8
GO:0034361∼very-low-density lipoprotein particle 2.8 4.47E-03 28.8
GO:0034385∼triglyceride-rich lipoprotein particle 2.8 4.47E-03 28.8
GO:0034364∼high-density lipoprotein particle 2.8 9.46E-03 19.8
GO:0032994∼protein-lipid complex 2.8 1.46E-02 15.8
GO:0034358∼plasma lipoprotein particle 2.8 1.46E-02 15.8
GO:0005576∼extracellular region 14.7 1.54E-02 1.9
GO:0044421∼extracellular region part 7.3 1.01E-01 2.0
GO:0005615∼extracellular space 5.5 1.03E-01 2.4
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Table 3. SignalP analysis – Proteins significantly altered in at least one pairwise comparison containing a signal peptide for active secretion.
Accession number Gene name Protein name
B0JYQ0 ALB ALB protein
F1MLW7 LOC100297192 Uncharacterized protein, immunoglobulin light chain, lambda gene cluster, identity: 97%
G3N0S9 LOC515150 Apolipoprotein R
A5D7Q2 N/A IgM precursor
V6F9A3 ApoC3 Apolipoprotein C-III
F1MZ96 N/A IGK protein
Q29437 N/A Primary amine oxidase, liver isozyme
Q5GN72 AGP Alpha-1-acid glycoprotein
A6QPP2 SERPIND1 SERPIND1 protein
P02769 ALB Serum albumin
Q2KIX7 N/A Protein HP-25 homolog 1
P01045 KNG2 Kininogen-2
Q9GLX9 SPON1 Spondin-1
A6QP39 MSLN MSLN protein
F2FB38 MUC16 Mucin-16
Q3ZCH5 AZGP1 Zinc-alpha-2-glycoprotein
P00978 AMBP Protein AMBP
P12763 AHSG Alpha-2-HS-glycoprotein
Q32PA9 FKBP2 Peptidyl-prolyl cis-trans isomerase FKBP2
Q28042 OVGP1 Oviduct-specific glycoprotein
P81644 APOA2 Apolipoprotein A-II
F1MVK1 N/A Uncharacterized protein, complement C4-like isoform X3, identity: 93%
G3N1U4 SERPINA3–3 Serpin A3–3
F1N3Q7 APOA4 Apolipoprotein A-IV
F1 N036 DNAJC3 DnaJ homolog subfamily C member 3
F1MYN5 FBLN1 Fibulin-1
Q29RU4 C6 Complement component C6
Q28085 CFH Complement factor H
Q2KJH6 SERPINH1 Serpin H1
Q3T083 SDF2L1 Stromal cell-derived factor 2-like protein 1
A4IF88 RCN1 RCN1 protein
Genomes) pathway and GO categories biological process and
molecular function. Gene sets were considered as significantly
enriched with a FDR q-value of less than 0.05. All significantly
enriched gene sets of both animal models are listed in Table 4.
In the metabolic model, a lower number of significantly enriched
gene sets were detected than in the genetic model. Comparing
the Dry and Lact group, “KEGG proteasome” was enriched in
Dry. In the comparison of the Dry versus MH groups, “KEGG
complement and coagulation cascades” was overrepresented in
Dry.
The vast majority of significantly enriched gene sets was found
in the genetic merit model. Regarding MBD versus HFH, the KEGG
pathways “Complement and coagulation cascades”, “Systemic lupus
erythematosus”, and “Prion diseases” were more highly enriched in
MBD than in HFH. In the comparison of LFH and HFH, “KEGG
Ribosome” was enriched in LFH. In the comparison of LFH versus
MBD, the gene sets “Structural constituent of ribosome”and “KEGG
Ribosome” were enriched in LFH, whereas, for example, “KEGG
complement and coagulation cascades”, “KEGG systemic lupus
erythematosus”, and “immune response” were found to be more
over-represented in the MBD group (Table 4).
The most frequently enriched gene set among all comparisons is
the set “KEGG complement and coagulation cascades”, which was
significantly altered in the comparisons of MBD and HFH as well as
MBD versus LFH and Dry compared with MH.
To gain further insight of the KEGG pathways, biological
processes and molecular functions in which the significantly
altered proteins are involved, and to validate the results obtained
from the GSEA, we used DAVID to perform a gene ontology
analysis [30, 31].
Functional annotation clustering of all proteins that were found
to be significantly altered in the pairwise comparisons of the genetic
and/or the metabolic model resulted in seven enriched clusters.
These proteins were, for example, found to be assigned to the
GO terms “actin binding”, “lipid binding”, “enzyme inhibitor
activity”, and “immune response”. These findings are visualized
in Figure 6A using Proteomaps. In more detail, Figure 6B shows
the “Proteomaps” of proteins that were assigned to the gene sets
“KEGG complement and coagulation cascades” and “immune
response” as well as the DAVID GO cluster “immune response.” An
overview of significantly enriched annotation clusters (enrichment
score greater than 1.3) is shown in Table 5. A complete list of
GO terms in annotation clusters is available from Supplementary
Table S1.
Discussion
The antagonistic relationship between single trait selection for
increased milk yield and cow fertility has been well documented. Two
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Table 4. Results of the GSEA.
MBD > LFH LFH > MBD
KEGG complement and coagulation cascades Structural constituent of ribosome
KEGG systemic lupus erythematosus KEGG ribosome
Immune response
Response to wounding
Defense response
Response to external stimulus
MBD > HFH LFH > HFH
KEGG complement and coagulation cascades KEGG ribosome
KEGG systemic lupus erythematosus
KEGG prion diseases
Dry > MH Dry > Lact
KEGG complement and coagulation cascades KEGG proteasome
MH: Maiden heifer; Lact: postpartum lactating cows; Dry: postpartum non-lactating cows; LFH: Low fertility heifer; HFH: High fertility heifer; and MBD: Montbéliarde heifer.
Figure 6. Visualization of affected biological processes. Proteomap visualization of proteins significantly altered in abundance and related biological processes
from the genetic and the metabolic model (A). (B and C) Proteins related to “complement and coagulation cascades” and “immune response” in GSEA and
DAVID GO analysis. The tiles of the Proteomap are arranged according to the hierarchical KEGG pathway maps. Related functional categories are arranged in
adjacent regions and coded using similar colors. Areas of tiles represent protein abundances, weighted by protein size.
Table 5. Enriched annotation clusters from the DAVID GO analysis
of abundance-altered proteins from both models according to
the terms “biological process”, “molecular function”, and “KEGG
pathways”.
Annotation
cluster
Cluster enrichment
score
Cluster GO term
1 3.08 Cytoskeletal protein binding
2 2.71 Actin binding
3 2.47 Translation
4 1.90 Identical protein binding
5 1.69 Lipid binding
6 1.67 Enzyme inhibitor activity
7 1.39 Immune response
different animal models were established to study possible reasons
for impaired reproductive performance in different reproductive
organs and at several molecular levels. This study forms part
of a larger study examining the impact of lactation on the cow
metabolic status and follicular fluid metabolic profile [27], and on
the conceptus [38] and endometrial [39] transcriptome.
Strategy and reproducibility of the proteomic analysis
For proteomic analysis, the straight-forward and frequently applied
LFQ approach [28, 40] was chosen. To reduce undersampling, a
common problem in complex samples, we used long (50 cm) separa-
tion columns in combination with long gradients. Even though the
analysis of OF is challenging due to several high abundant proteins
such as albumin and the oviduct-specific protein, such as Oviductal
Glycoprotein 1 (OVGP1), we were able to identify more than 1500
proteins in each model. Other studies [4, 13, 41] achieved similar or
lower numbers of identified proteins, leading us to the conclusion
that the analytic depth of our dataset is reasonably high. To identify
the overlap with previously identified proteins, we compared our
dataset with the OF proteomes of the above-mentioned studies.
Comparison of 1976 proteins from both models in our study to data
in the literature revealed that 1101 proteins (56%) had already been
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reported to be present in bovine [4, 13] and equine [42] or ovine [41]
OF. Thus, 875 novel proteins were identified in OF by our approach.
Since the genetic diversity between individual cows in each of
the groups is considerably higher than in cell lines or inbred strains
of laboratory animals frequently used for “omics” approaches, the
reproducibility among different individuals of one group is especially
challenging. A comparison of the qualitative results of the proteomic
approach revealed a high level of consistency, with only 172 of
a total of 1299 identified proteins detected exclusively in a single
animal in the case of the LFH group (Figure 1). This underlines the
quality of the OF samples as well as the proteomic approach, both
indispensable for analytically meaningful proteomic results.
Comparing the identified proteins from the six different groups,
we found an overlap of around two-thirds of the identified proteins
in all three groups in the genetic as well as in the metabolic model.
In a study of bovine OF by Lamy et al. [4], approximately 72% of
proteins identified in the oviduct ipsilateral to the CL were common
between four stages of the estrous cycle. However, in our study,
we analyzed different metabolic stages and animals with a different
genetic background. As shown in Figure 2, some proteins were
detected in only one group, especially in MBD and Lact. However,
it has to be considered that the abundance of these proteins may be
below the detection limit in the other groups, and that proteins which
were not identified should not be regarded as absent.
In order to gain a deeper understanding of the relevance of the
abundance altered proteins, all proteins were classified according
to their relative abundance based on LFQ intensities. Abundance is
indicated as low, medium, or high with an LFQ intensity of <25%,
25–75%, or >75 of the maximum intensity, respectively. Abundance
categories for each protein are listed in Supplementary Tables S2–S7.
Interestingly, except for one protein, all significantly altered proteins
in both the genetic and the metabolic model were either of medium
or high abundance.
Origin of oviduct fluid proteins
Although several of the proteins significantly altered in abundance
in our OF analysis have been reported in other studies of the OF
proteome [4, 13, 41, 42], it is unclear whether these proteins have
been actively secreted into the oviduct. Among the proteins that
are altered in abundance, 22% contain a signal peptide that targets
the protein for translocation across the endoplasmic reticulum [43].
Moreover, DAVID GO analysis according to the term “cellular com-
ponent” showed that 14.7% of the abundance-altered proteins were
associated with the term “extracellular region”. Regarding the total
set of identified proteins, 14% of the proteins were found to contain
a signal peptide for secretion. This suggests that secreted proteins
are predominantly affected by abundance alterations, indicating an
active regulation of the levels of these proteins in the OF.
In a proteomic analysis of ewe cervix, uterus, and ewe cervix,
uterus and oviduct fluid, Soleilhavoup et al. [41] also found 14% of
the proteins to be classified as “secreted” in the GO analysis. Similar
results have also been reported for bovine OF [4]. Contamination
by intact cells was prevented in our study by using gentle flushing
instead of squeezing the oviducts and by removal of cells and cell
debris prior to sample processing. Therefore, proteins that were not
found to be actively secreted are either non-canonically secreted,
may derive from cells that have undergone cell death or may not
be annotated as secreted in the database.
Alminana et al. [44] investigated the protein composition of
extracellular vesicles (EV) obtained from in vivo- and in vitro-derived
BOEC. They identified a set of proteins potentially important for
gamete- and embryo-oviduct interactions and therefore suggested
that EVs are a possible mechanism for the release of proteins into the
oviduct and their transport to the embryo. Some of these proteins are
also among the set of differentially abundant proteins in the present
study, for example, DEAD-box helicase 17 (DDX17), OVGP1, GSN,
STXBP1, or ANXA5, indicating that proteins identified in our study,
which are not annotated as secreted could also derive from exosomes
and microvesicles.
Metabolic stress as well as genetic predisposition
affect the oviduct fluid proteome
The oviduct plays a key role in fertilization and early embryonic
development and has gained increasing attention in the context of
dairy cow infertility, since a considerable proportion of embryonic
losses occurs prior to maternal recognition of pregnancy around Day
16 [45, 46]. Indeed, it has been reported that in high-producing dairy
cows, up to 50% of embryos may be no longer viable by Day 7 [21].
Oviduct fluid provides the microenvironment for sperm, oocyte, and
the early embryo and is composed mainly of proteins, lipids, and
amino acids [47]. Forde et al. [27] analyzed animals from the same
model as in the present study and demonstrated that lactation has a
substantial impact on the metabolic status and the follicular fluid
metabolomic profile of dairy cows. They reported an increase in
concentrations of circulating NEFA and beta-hydroxybutyrate, as
well as a decrease of insulin, IGF1, and glucose in postpartum lac-
tating cows in comparison to nulliparous heifers. Overall, their data
showed distinct changes in the metabolic status of lactating cows
compared with non-lactating cows and heifers. In agreement with
this finding, most of the 37 differentially abundant proteins were
detected comparing Lact and MH followed by Dry versus MH. This
is in accordance with Bauersachs et al. [39], analyzing differences
in the endometrial transcriptome in the same metabolic model as
used here. They found only minor differences in endometrial gene
expression in non-lactating and lactating cows as opposed to heifers
versus both postpartum groups. Among the comparisons within the
metabolic model, seven proteins were significantly altered in abun-
dance in more than one comparison. Three of these proteins were
less abundant in the postpartum groups, Lact and Dry compared
with MH: Prostaglandin reductase 1 (PTGR1), Elongation factor
1-beta (EEF1B), and Epoxide hydrolase 2 (EPHX2), which are all
highly abundant in our data set. To our knowledge, a role of EEF1B
in OF has not been described thus far. In contrast, EPHX2 was
more expressed in the prepubertal compared with the postovulatory
phase in a study analyzing the gene expression in porcine oviduct
[48]. Epoxide hydrolase 2 binds to specific epoxides and converts
them to the corresponding dihydrodiols. Prostaglandin reductase 1
catalyzes the conversion of leukotriene B4 into the biologically less
active 12-oxo-leukotriene B4, which is the key step of the metabolic
inactivation of leukotriene B4, and has previously been described
to play a role in maternal recognition of pregnancy in a proteomic
analysis of equine uterine fluid [49].
DEAD-box helicase 17 and Osteoclast-stimulating factor
1 (OSTF1), two proteins with high and medium abundance,
respectively, were found to be significantly more abundant in Lact
compared with MH and Dry. DEAD-box helicase 17 was around 1.6
times higher in Lact and is believed to be involved in embryogenesis,
spermatogenesis, and cellular growth and division based on its
distribution pattern [50, 51]. In addition, the protein has been
identified in bovine oviductal EV [44]. OSTF1 is believed to induce
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bone resorption, but has only been described in the context of female
mammalian reproduction in human and murine embryos in vitro in
response to increasing ammonium concentrations [52].
As evident from Figure 4, a remarkably higher number of dif-
ferentially abundant proteins was detected in the genetic model
compared with the metabolic model. Among the genetic model,
most abundance-altered proteins were detected between MBD and
the two Holstein groups. Together with the lower number of dif-
ferentially expressed proteins in the metabolic model, this leads to
the assumption that genetic differences are prevalent regarding the
protein composition of the OF. Nevertheless, between LFH and
HFH, differing only in their EBV for fertility, 37 proteins were
found to be altered in abundance. Principal component analysis of
the samples of the genetic model also showed a clear separation
between the two Holstein groups at the proteome level. Previous
studies also comparing Holstein dairy cows with a similar genetic
merit for milk production but with a negative or positive EBV
for reproduction showed a distinct effect of the genetic merit for
fertility traits on the reproductive efficiency. Cows with a good
genetic merit for reproduction had higher postpartum BCSs, cir-
culating concentrations of insulin and insulin-like growth factor I,
and reduced calving to conception intervals [19]. Moreover, it has
been shown that the EBV for fertility also has an influence on
follicular fluid and serum concentrations of amino acids as well as
on fatty acids concentrations in non-pregnant cows [20]. One of the
proteins significantly higher (2.6-fold) in HFH compared with LFH
is oviduct-specific glycoprotein (OVGP), which is one of the most
abundant proteins in OF and has been discussed in several studies
and reviews [17, 47]. For instance, an OVGP1-heparin complex
has been reported to be involved in zona pellucida modification
prior to fertilization that affects sperm binding and contributes
to the regulation of polyspermy in pig [53, 54]. Oviduct-specific
glycoprotein was also described to interact with spermatozoa [55]
in the bovine and to promote sperm capacitation [56], viability, and
motility [57]. Moreover, the addition of OVGP leads to increased
embryo development in vitro in pigs [58] and goats [17, 59]. An
increase of OVGP1 in the HFH group may therefore contribute to
an improved fertility compared with those with a lower genetic merit
for reproduction.
A substantial proportion of affected proteins is
assigned to “Complement and coagulation cascades”
and “Immune system” processes
Functional classification of abundance-altered proteins was per-
formed using DAVID GO analysis in addition to GSEA. As shown
in Table 4, significantly enriched gene sets in these comparisons are
mainly related to the KEGG pathway “Complement and coagulation
cascades”, Moreover, DAVID GO functional annotation revealed a
significant enrichment of the cluster “Immune response”, which is
in accordance to previous studies showing that the oviduct plays a
vital role in the regulation of immunological processes. As compre-
hensively reviewed [60, 61], the oviduct contains a unique immune
system able to distinguish among pathogens, allogeneic sperm, and
the semi-allogeneic embryo, which is a crucial premise for successful
fertilization and early embryo survival. Proteins involved in the gene
sets and GO cluster related to immune response are graphically
illustrated in Figure 6B and C. In the pairwise comparison of MBD
and LFH, we found the macrophage migration inhibitory factor
(MIF) to be more highly abundant in LFH. Migration inhibitory
factor is involved in cell-mediated immunity, immunoregulation, and
inflammation and plays a role in the regulation of macrophage
function in host defense [62]. Migration inhibitory factor mRNA
and protein expression was increased during the postovulatory phase
compared with estrus and the luteal phase in Japanese black heifers
[63]. Migration inhibitory factor has been reported to be secreted
into the oviduct [13] and was also identified in the ewe OF [41];
however, its role in early embryogenesis remains unclear.
In addition to MIF, several immunoglobulins were found to be
significantly altered comparing MBD and LFH, but with higher
abundance in MBD. Basic Local Alignment Search Tool (BLAST)
search (https://blast.ncbi.nlm.nih.gov/Blast.cgi) of the sequences
of uncharacterized proteins with the UniProt accession numbers
F1MLW7, A5D7Q2, G5E604, and G3N0V0 showed 97–100%
identity with immunoglobulin light chain, lambda gene cluster,
IgM precursor, immunoglobulin light chain variable region, and
secreted immunoglobulin gamma2 heavy chain constant region,
respectively. Immunoglobulins are well known to be among the
major components of OF [64, 65], which is in agreement as the
significantly altered proteins were also highly abundant in our study.
Another protein related to immune response is the “deleted in
malignant brain tumors 1”(DMBT1) protein with a 2.9-fold increase
in Dry compared with MH. Deleted in malignant brain tumors 1 was
also 4.6-fold higher in Lact compared with MH (P = 0.08). It has
been shown to bind surfactant protein D and is suggested to play
a role in the interaction of tumor cells and the immune system. In
equine and porcine, DMBT1 was found to be expressed by oviduct
epithelial cells. Moreover, preincubation of oocytes with recombi-
nant DMBT1 increased the monospermic fertilization rate, which
was also observed by IVF under supplementation of oviductal fluid
[66]. Ambruosi et al. [66] therefore suggest that DMBT1 acts as a
bridge between oocytes and sperm cells or oocytes and oviductal cells
and mediates their interaction by linking other associated proteins.
Moreover, the DMBT1 gene has previously been detected among a
set of genes with up-regulated expression in endometria from Day 19
pregnant heifers of the same animal model as in our study compared
with pregnant non-lactating and lactating dairy cows [39].
Additionally, two proteins of the complement cascade, Com-
plement component C6 and Complement factor H (CFH) were
found to be significantly altered in pairwise comparisons. Both
were found to be 2.2-fold higher in Dry compared with Lact and
have previously been identified in OF in cattle and ewe [13, 41].
C6 is part of the membrane attack complex that can be incor-
porated into the cell membrane and cause cell lysis, while CFH
has been described to play a role in the regulation of complement
activation. In a study by Maillo et al. [67] examining the effect of
multiple embryos on the transcriptome of the bovine oviduct, most
of the downregulated genes in pregnant heifers were related with
the complement system, inflammation, or major histocompatibility
complex.
Interestingly, abundance alterations of proteins related to
immune response were only found in comparisons within the
metabolic model and comparing the Holstein groups to MBD, but
not between LFH and HFH. Moreover, all of the proteins discussed
above exhibited high abundance, that is, a LFQ intensity above
75% of the maximum intensity. Our data suggest that differences
in the immune response of the OF are therefore related to different
breeds or changes in the metabolic status, but may not be linked
with the EBV for fertility. Moreover, we found that some of the
proteins related to immune response in the metabolic model were
higher in Dry and Lact than in MH (SERPIND1 protein, APOA2,
APOA4, and DMBT1) but none was higher in MH compared with
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the postpartum groups. This suggests that metabolic stress leads to
an enhancement of proteins involved in immune system processes.
Proteins commonly affected in the metabolic as well as
in the genetic model
Despite the higher number of altered proteins in the genetic model
compared with the metabolic model, the question remains whether
all of these proteins are related to fertility. Therefore, we investigated
the overlap of both models to identify proteins that are affected by
the metabolic status as well as the genetic merit for fertility. Interest-
ingly, a set of four proteins were found to be altered in abundance
in both models. One of these proteins is Actin-related protein 2/3
complex subunit 1B (ARPC1B), which was 1.7-fold higher in Lact
compared with MH and also 1.7-fold increased in MBD compared
with LFH. Actin-related protein 2/3 complex subunit 1B functions
as a subunit of the human Arp2/3 complex involved in the control
of actin polymerization in cells [68] and has also been identified in
bovine OF [13]. The functional role of ARPC1B in the OF remains
unclear.
An uncharacterized protein with the UniProt accession number
F1MZ96 was also found in both models. It was 2.0-fold higher in
Dry compared with MH and showed a 3.6-fold increase in MBD
compared with LFH. Basic Local Alignment Search Tool search of
the protein sequence resulted in a 98% overlap with IGK protein
(immunoglobulin kappa locus), suggesting that this protein may also
be involved in the immune response.
Alpha-1-acid glycoprotein (AGP), an acute phase plasma protein,
proved to be 2.1-fold increased in Lact compared with MH and 3.4-
fold increased in MBD versus LFH. Kowsar et al. (2014) suggested a
secretion of AGP by BOEC to regulate antimicrobial processes [69].
Moreover, they hypothesized that oviductal AGP could regulate the
expression of Tumor necrosis factor (TNFA), a pro-inflammatory
cytokine, by the BOEC. A study by Liu et al. (2014) found evidence
that locally produced AGP may be involved in protecting sperm
from phagocytosis by polymorphonuclear neutrophils in the bovine
oviduct [70].
Abundance of SERPIND1, which was also associated with the
previously discussed DAVID GO term “immune response”, was
altered in three comparisons. It was around three times higher in
MBD compared with both Holstein groups and 1.9-fold increased
in Lact compared with MH. SERPIND1 was identified among a set
of inhibitors of acrosomal and other lysosomal proteases like α-1-
antiproteinase/antitrypsin and different other serpins in bovine OF
[13].
It should be noted that all proteins showing abundance alter-
ations in both models were more abundant in MBD than in the
Holstein groups and also more abundant in the postpartum groups
Dry and Lact compared with MH. Except for ARPC1B, all of
these proteins were found to contain a signal peptide for active
secretion and have an immune system-related function, although
AGP and IGK protein were not included in the annotation cluster
“immune response”. This is consistent with the results discussed
above indicating that proteins related to immune response were not
altered in abundance in the comparison of LFH and HFH and are
therefore not affected by the EBV for fertility. Of interest, these
proteins were all highly abundant, indicating that the concentrations
of the respective proteins have a physiological effect in the OF.
Moreover, this adds to our finding that metabolic stress results in
an increase of proteins that play a role in defense response, as these
proteins were less abundant in MH than in the other groups of the
metabolic model.
In summary, we were able to show that the genetic predis-
position for fertility and breed have a strong impact on the OF
proteome, while the impact of metabolic stress was lower, suggesting
a robustness of the oviduct environment. The remarkably high
fraction of immune response-related proteins suggests that reduced
reproductive success in both models may be triggered by alterations
of the immune system components in the microenvironment for the
gametes and the early embryo.
Supplementry data
Supplementary data are available at BIOLRE online.
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8 Appendix 
8.1 Abbreviations 
 
ActD Actinomycin D 
CC Cumulus cell 
CID Collision-induced dissociation 
CL Corpus luteum 
COC Cumulus-oocyte-complex 
DAVID Database for annotation, visualization and integrated discovery 
DIGE Difference gel electrophoresis 
DMSO Dimethyl sulfoxide 
DTT Dithiothreitol 
EBV Estimated breeding value 
ECS Estrous cow serum 
EGA Embryonic genome activation 
FA Formic acid 
FDR False discovery rate 
FECUND Fundamental cattle reproduction study 
FSH  Follicle-stimulating hormone 
GO Gene ontology 
GSEA Gene set enrichment analysis 
GV Germinal vesicle 
GVBD Germinal vesicle breakdown 
HFH High fertility Holstein heifers 
IAA Iodoacetamide 
ICAT Isotope-coded affinity tag 
iTRAQ Isobaric tags for relative and absolute quantitation 
IVF in vitro fertilization 
IVM in vitro maturation 
IVP in vitro production 
KEGG Kyoto encyclopedia of genes and genomes 
LC Liquid chromatography 
LFH Low fertility Holstein heifers 
LFQ Label-free quantification 
LH Luteinizing hormone 
MALDI-TOF Matrix-assisted laser desorption/ionization time of flight 
MBD Montbéliarde 
MH Maiden heifer 
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MII Metaphase II 
MII AD Actinomycin D-treated metaphase II oocytes 
MS Mass spectrometer 
OF Oviduct fluid 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate-buffered saline 
PVP Polyvinylpyrrolidone 
REVIGO Reduce and visualize gene ontology 
SILAC Stable isotope labelling by amino acids in cell culture 
TCEP Tris-(2-carboxyethyl)-phosphine 
TCM Tissue culture medium 
TMT Tandem mass tag 
ULF Uterine luminal fluid 
UTP Uridine-5'-triphosphate 
ZP Zona pellucida 
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8.2 Supplementary 
The following Supplementary tables for all projects are available on the compact disc 
appended to this dissertation. 
8.2.1 Supplementary tables Main project 
Supplementary table 1: Full list of proteins identified in GV, MII and MII AD oocytes in 
all replicates with corresponding LFQ intensity values. 
Supplementary tables 2 to 7: Significantly altered proteins in the comparison of GV and MII 
(2), GV and MII AD (3) and MII and MII AD (4) oocytes; proteins with significantly lower 
(5) or higher (6) abundance in both MII control and MII ActD-treated compared to GV 
oocytes; proteins significantly altered in opposite directions in MII and MII AD compared 
to GV oocytes (7). 
Supplementary tables 8 to 12: Enriched biological processes for proteins higher or lower 
abundant in both MII and MII AD compared to GV according to STRING analysis (8); 
significantly enriched GO terms in the comparison of GV and MII (9), GV and MII AD (10) 
and MII and MII AD (11); Significantly enriched GO terms for proteins with higher 
abundance in MII compared to GV, which are not enriched in MII AD compared to GV (12). 
Supplementary tables 13 to 15: Significantly enriched gene sets in the comparison of GV 
and MI (13), GV and MII AD (14) and MII and MII AD (15). 
8.2.2 Supplementary tables Side project A 
Supplementary table 1: Full list of proteins identified in ULF in all groups and replicates 
with corresponding LFQ intensity values. 
 
Supplementary tables 2 to 4: Significantly altered proteins in the comparison of LFH and 
HFH (2), LFH and MBD (3) and HFH and MBD (4). 
 
Supplementary tables 5 to 7: Significantly enriched gene sets in the comparison of LFH 
and HFH (5), LFH and MBD (6) and HFH and MBD (7). 
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Supplementary tables 8 to 10: Significantly enriched GO terms in the comparison of LFH 
and HFH (8), LFH and MBD (9) and HFH and MBD (10). 
 
8.2.3 Supplementary tables Side project B 
Supplementary table 1: List of annotation clusters and GO terms of abundance-altered 
proteins from both models according to the terms “biological process”, “molecular function” 
and “KEGG pathways. 
 
Supplementary tables 2 to 7: Significantly altered proteins in the pairwise comparisons of 
the groups of the metabolic model and the genetic model. 
 
Supplementary table 8: Full list of all identified proteins from the metabolic model with their 
respective LFQ intensities and their relative abundance.  
 
Supplementary table 9: Full list of all identified proteins from the genetic merit model with 
their respective LFQ intensities and their relative abundance. 
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8.3 List of publications and conference contributions 
8.3.1 Articles 
Influence of metabolic status and genetic merit for fertility on proteomic composition 
of bovine oviduct fluid 
Gegenfurtner, K., Fröhlich T., Kösters M., Mermillod P, Locatelli Y., Fritz S, Salvetti P., 
Forde N., Lonergan P., Wolf E., Arnold G.J.; Biol Reprod, 2019 
 
Genetic merit for fertility alters the bovine uterine luminal fluid proteome 
Gegenfurtner, K., Fröhlich T., Flenkenthaler F., Kösters M., Fritz S., Desnoes O., Le Bourhis 
D., Salvetti P., Sandra O., Charpigny G., Mermillod P., Lonergan P., Wolf E., Arnold G.J.; 
Biol Reprod, in press 
 
8.3.2 Scientific talk 
V International Conference on Analytical Proteomics, July 3 – 6, 2017, Caparica, 
Portugal 
Influence of Metabolic Status and Genetic Predisposition on Proteomic Composition of 
Bovine Oviduct Fluids 
 
8.3.3 Poster presentations 
50. Jahrestagung Physiologie & Pathologie der Fortpflanzung und gleichzeitig 42. 
Veterinär-Humanmedizinische Gemeinschaftstagung, February 15 – 12, 2017, 
Martinsried, Germany 
Der Einfluss des metabolischen Status und des Zuchtwerts für Fruchtbarkeit auf die 
Proteomzusammensetzung von boviner Oviduktflüssigkeit 
 
Meyer K., Fröhlich T., Kösters M., Riedel E., Fritz S., Salvetti P., Forde N., Lonergan P-, 
Wolf E. and Arnold G.J. 
 
V International Conference on Analytical Proteomics, July 3 – 6, 2017, Caparica, 
Portugal 
Influence of Metabolic Status and Genetic Predisposition on Proteomic Composition of 
Bovine Oviduct Fluids  
 
Appendix   92 
 
Meyer K., Fröhlich T., Kösters M., Fritz S., Salvetti P., Forde N., Lonergan P-, Wolf E. 
and Arnold G.J.  
 
16th Human Proteome Organisation World Congress, September 17 – 21, 2017, 
Dublin, Ireland 
Proteomic Analysis of the Impact of Metabolic Status and Genetic Predisposition on 
Oviduct Fluid Composition 
 
Meyer K., Fröhlich T., Kösters M., Fritz S., Salvetti P., Forde N., Lonergan P-, Wolf E. 
and Arnold G.J. 
 
44th Annual Conference of the IETS, January 13-16, 2018, Bangkok, Thailand 
Influence of Metabolic Status and Genetic Merit for Fertility on Proteomic Composition of 
Bovine Uterine Luminal Fluid 
 
Gegenfurtner K., Fröhlich T, Kösters M., Fritz S., Salvetti P., Forde N., Lonergan P-, Wolf 
E. and Arnold G.J. 
 
8.3.4 Awards and travel grants 
Poster award and travel grant: V International Conference on Analytical Proteomics, 
July 3 – 6, 2017, Caparica, Portugal 
Influence of Metabolic Status and Genetic Predisposition on Proteomic Composition of 
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Meyer K., Fröhlich T., Kösters M., Fritz S., Salvetti P., Forde N., Lonergan P-, Wolf E. and 
Arnold G.J. 
 
Travel grant of the DGPF for 16th Human Proteome Organisation World Congress, 
September 17 – 21, 2017, Dublin, Ireland 
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